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xAbstract
The immune response against M. tuberculosis is multifactorial, involving a network of innate 
and adaptive immune responses. Characterization of the immune response, a clear 
understanding of the dynamics and interplay of different arms of the immune response and 
the identification of infection-stage specific biomarkers are critical to allow the 
development of better tools for combating tuberculosis. In an attempt to identify such 
biomarkers, we studied pulmonary tuberculosis patients and their contacts in Addis Ababa, 
Ethiopia as part of EDCTP and BMGF funded tuberculosis projects by using multiplex 
techniques. We analysed 45 genes using the Multiplex Ligation Dependent Probe 
Amplification (MLPA) technique and the expression of IL-4d2, BLR1, MARCO, CCL-19, IL7R, 
Bcl2, FcgR1A, MMP9, and LTF genes discriminate TB cases from their healthy contacts. 
FoxP3, TGFb1 and CCL-19 discriminate latently infected from uninfected contacts. Single 
genes predict with an area under the Receiver Operating Characteristic (ROC) curve of 0.68
to 0.85 while a combination of genes identified up to 95% of the different groups. Similarly, 
the multiplex analysis of cytokines and chemokines also showed that single or combinations
of plasma cytokines and chemokines discriminate between different clinical groups 
accurately. The median plasma level of EGF, fractalkine, IFN-g, IL-4, MCP-3 and IP-10 is 
significantly different (p<0.05) in active tuberculosis and non active tuberculosis infection 
and the median plasma levels of IFN-g, IL-4, MCP-3, MIP-1b and IP-10 were significantly 
different (p<0.05) before and after treatment. We also found a significant difference 
(p<0.05) in plasma levels of cytokines of patients infected with the different lineages and 
different families of the modern lineage. The plasma level of IL-4 was significantly higher in 
patients infected with lineage 3 (p<0.05) as compared to lineage 4 and the CAS family-
infected patients had a higher plasma level of IL-4 (P<0.05) as compared to patients infected 
with H and T families but there was no difference between H and T families.
We identified genes and cytokines which had been reported from other studies in different 
settings and we believe that these molecules are very promising biomarkers for classifying 
active tuberculosis, latent infection, absence of infection and treated infection. These 
markers may be suitable for the development of clinically useful tools but require further 
validation and qualification in different populations and in larger studies.
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Abstrak
Die immuunrespons teen M. tuberculosis is multifaktoriaal en betrek ‘n netwerk van nie-
spesifieke and spesifieke immuunresponse. Karakterisering van die immuunrespons, ‘n 
duidelike insig in die dinamika en tussenspel deur die verskillende arms van die 
immuunrespons en die identifikasie van spesifieke biomerkers is krities belangrik om die 
ontwikkeling van nuwe hulpmiddels teen tuberkulose te bevorder. In ‘n poging om sulke 
biomerkers te identifiseer het ons pulmonale tuberkulose pasiënte en hulle kontakte in 
Addis Ababa, Etiopië, as deel van die EDCTP en BMGF befondste tuberkulose projekte 
bestudeer met multipleks tegnieke. Ons het 45 gene analiseer met ‘Multiplex Ligation 
Dependent Probe Amplification (MLPA)’ en gevind dat die geenuitdrukking van IL-4•2, BLR1, 
MARCO, CCL-19, IL7R, Bcl2, Fc•R1A, MMP9, en LTF TB pasiënte van hulle kontakte 
onderskei. FoxP3, TGF•1 en CCL-19 onderskei tussen latent infekteerde en ongeïnfekteerde 
kontakte. Enkele gene voorspel met ‘n area onder die ‘Receiver Operating Characteristic 
(ROC)’ kurwe van 0.68 tot 0.85 terwyl die kombinasie van gene 95% van die verskillende 
groepe identifiseer. Soortgelyk het multipleks analise van sitokiene en chemokiene 
verskillende kliniese groepe akkuraat van mekaar onderskei.  Die mediane plasmavlakke van 
EGF, fractalkine, IFN-•, IL-4, MCP-3 en IP-10 is beduidend verskillend (p<0.05) in aktiewe 
tuberkulose en nie-aktiewe tuberkulose infeksie en die mediane plasmavlak van IFN-•, IL-4, 
MCP-3, MIP-1• en IP-10 was beduidend verskillend voor en na behandeling. Ons het ook 
beduidende verskille (p<0.05) in plasmavlakke van sitokiene in pasiënte gevind wat 
infekteer is met verskillende stamme and verskillende families van die moderne stamme. 
Die plasmavlak van IL-4 was beduidend hoër in pasiënte wat infekteer is met stam 3 
(p<0.05) teenoor stam 4 en die CAS familie-infekteerde pasiënte het ‘n hoër plasmavlak van 
IL-4 (p<0.05) teenoor pasiënte met H en T familie infeksie hoewel daar geen versikke was 
tussen die H en T families nie. 
Ons het gene en sitokiene identifiseer wat deur ander werkers onder verskillende 
omstandighede ook beskryf is en ons glo dat hierdie molekules baie belowende biomerkers 
is om aktiewe tuberkulose, latent tuberkulose, die afwesigheid van infeksie en behandelde 
infeksie van mekaar te onderskei. Hierdie merkers mag toepaslik wees vir die ontwikkeling 
van bruikbare kliniese hulpmiddele maar benodig verdere validasie en kwalifikasie in 
verskillende populasiegroepe en in groter studies.
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1CHAPTER 1
1. General Background
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21.1 Introduction
1.1.1 Tuberculosis
Tuberculosis (TB) is one of the most devastating diseases of mankind and remains a major 
health threat in Africa with much higher rates in the Sub-Saharan part of the continent. The 
Mycobacterium tuberculosis complex (MTBC) is the cause of TB and encompasses M. 
tuberculosis, M. bovis, M. africanum, M. canettii, M. pinnipedii, M. caprae, and M. microti,
which have 99% genetic similarity and identical 16S sRNA (Boddinghaus et al.; 1990; 
Sreevatsan et al.; 1997). M. tuberculosis is the predominant cause of TB in humans.
M. tuberculosis is an acid fast, facultative intracellular aerobic pathogen that has straight or 
curved rod morphology and exists either singly or in clusters. M. tuberculosis is a slow 
growing bacterium and divides once every 18-24 hours requiring 18-21 days before visible 
colonies develop on solid medium (Salyers and Whitt; 1994). The cellular envelope of M. 
tuberculosis consists of a plasma membrane and a highly unusual cell wall. The plasma 
membrane consists of a classical bilayer structure. The elaborate distinctive features of the 
mycobacterial cell walls include the lipoarabinomannan (LAM), lipomannan, mycolyl-
arabinogalactan, phosphatidyl-myoinositol mannoside, sulfatide, cord factor, and other 
acylated trehaloses, phenolic glycolipids, lipoligosaccharides, and other attenuated lipids. 
Many of these have been shown to be involved in the virulence and pathogenesis of this 
bacillus. LAM, a predominant component of the cell wall, is a virulence factor for M. 
tuberculosis, which activates macrophages (MØ) and scavenges reactive oxygen 
intermediates (Brennan, PJ and Nicaido, H ; 1995; Nigou et al.; 2003).
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31.1.2 Epidemiology of Mycobacterium tuberculosis infection
Mycobacterium tuberculosis was first identified as the causative agent of TB by Robert Koch 
in 1882. It is an extraordinary effective human pathogen infecting one-third of the world’s 
population with only 10% of these people developing active disease from the primary 
infection, in most cases within the first two years, whereas the remaining 90% of cases 
remains non-infectious and symptom free. The presence of underlying factors, which 
weaken the immune system, including chronic diseases like diabetes, alcoholism, 
malnutrition, stress and above all HIV/AIDS, increase the risk of developing the disease. M. 
tuberculosis infected HIV positive subjects have a 10% annual risk of developing active TB as 
opposed to the 10% life time risk in HIV negative individuals (Kaufmann and McMichael; 
2005). 
TB is the world’s second most common cause of death from all infectious diseases, next to 
HIV/AIDS. In 1993 the World Health Organization (WHO) declared TB as a ‘global 
emergency’ (WHO; 1994). There were 8.8 million new cases of TB in 2010, 1.1 million 
(range, 0.9–1.2 million) deaths from TB among HIV-negative people and an additional 0.35 
million (range, 0.32–0.39 million) deaths from HIV-associated TB. Of the 8.8 million incident 
cases in 2010, 1.1 million (13%) were among people living with HIV. Asia and Africa reported 
most numbers of cases in 2010 with 59% and 26% respectively; smaller proportions of cases 
occurred in the Eastern Mediterranean Region (7%), the European Region (5%) and the 
Region of the Americas (3%) (Figure 1-1). The 22 High Burden Countries (HBCs) accounted 
for 81% of all estimated cases worldwide (WHO; 2011).
Stellenbosch University  http://scholar.sun.ac.za
4Figure 1-1  Global Tuberculosis incidence rates, 2010 (WHO; 2011) .
The 22 high burden countries are listed by name and nine of them are in Sub-Saharan Africa
In Ethiopia, the incidence of TB is estimated at 240 new cases per 100,000 populations with 
a prevalence of 394 per 100,000 populations and the country is rated 7th among the 22 high 
burden countries. The mortality rate of all cases of TB is estimated to be 35 per 100,000
populations (figure 1-2). Fifteen percent of tested TB patients are HIV positive (WHO; 2011).
A
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5Figure 1-2 Tuberculosis trends in in Ethiopia (WHO; 2011).
Trends in estimated prevalence of TB in Ethiopia 1990-2010 (A), mortality excluding HIV 
1990-2010 (B) and HIV-TB positive patients (blue) who are taking co-trimoxazole preventive 
therapy (CPT) (pink) and ART (brown) 2005-2010 (C). The shading areas in”A”and “B” 
represent uncertainity areas 
1.1.3 Pathogenesis of tuberculosis
The inhalation of small size respiratory droplet nuclei (1-2mm or less) through the 
respiratory tract is the commonest route of entry of the tubercle bacillus. The respiratory
droplet nuclei are small enough in size to pass into the lower respiratory tract escaping the 
anatomical barriers of nasopharynx and upper respiratory tract (Schluger and Rom; 1998). 
M. tuberculosis does not infect the respiratory bronchial epithelium (McDonough and Kress; 
1995) and studies indicated that the bronchial epithelium can produce antimicrobial 
peptides with a wide spectrum of activity (Diamond et al.; 1991). Phagocytic cells mainly 
macrophages take up the bacteria once inhaled droplets pass into the lower respiratory 
B
C
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6tract and are deposited in the alveolar spaces, which assist in the induction of a rapid 
inflammatory response and accumulation of cells. Although alveolar macrophages are the 
first cells to engulf, dendritic cells and monocyte-derived macrophages also take part in the 
phagocytic process (Henderson et al.; 1997; Thurnher et al.; 1997).
Endocytosis of M. tuberculosis involves multiple receptors (Figure 1-3) such as complement, 
FcR, surfactant protein A (Sp-A) and its receptors, scavenger receptor class A, TLR, CD14 
mannose receptors and the DC-specific intercellular adhesion molecule-3-grabbing 
nonintegrin (DC-SIGN) (Ernst; 1998). Some receptors allow silent entry (CR), and others 
induce defense mechanisms (FcR) (Hirsch et al.; 1994; Aderem and Underhill; 1999). The 
subsequent intracellular fate of mycobacteria is considered as predetermined by the mode 
of entry into macrophages (Kleinnijenhuis et al.; 2011), however, experiments have shown 
that intracellular trafficking of M. tuberculosis was not significantly altered by blocking 
individual receptors (Ernst; 1998).
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7Figure 1-3 Endocytosis receptors in the recognition of mycobacteria (Kleinnijenhuis et al.; 
2011).
Both intracellular and extracellular receptors are involved in this process. Complement 
receptors are primarily responsible for uptake of opsonized M. tuberculosis and scavenger 
receptors for uptake of nonopsonized M. tuberculosis. TLRs play a central role in immune 
recognition of M. tuberculosis. Depending on the type of receptors, recognition of 
mycobacteria leads for intracellular cascading which in turn will lead to the activation of 
transcription of NF-•B, and induction of secretion of the of pro (+) and anti (-) inflammatory 
cytokines and chemokines. 
Once organisms have made their way into the lung, they have four potential fates (van 
Crevel et al.; 2002; van Crevel et al.; 2003).
i. Killing and elimination of the bacilli with the initial host immune response, and these 
individuals do not develop TB due to this exposure event. No clinical or 
immunological evidence of this interaction is apparent.
Uptake of M. tuberculosis
Complement 
receptor Scavenger 
receptor
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8ii. Immediately after infection the bacilli can grow and multiply, causing clinical disease 
(primary TB).
iii. Development of ‘latent infection’ where the bacilli persist in a sub clinical (quiescent) 
form. The bacteria may become dormant or may persist at low numbers, and are 
prevented from unchecked replication by the immune system and never cause 
disease at all. This phase is manifested only as positive tuberculin skin test (latent 
TB) or positive interferon gamma release assay.
iv. Reactivation of the dormant bacilli or escape from the quiescent phase with 
resultant disease (reactivation TB).
1.1. 4 Immunology of tuberculosis
The protective response to M. tuberculosis is complex and multifaceted involving many 
components of the immune system, mainly the result of productive cooperation between 
macrophages and T-cell populations (Kaufmann et al.; 2005) (Figure 1-4).
Stellenbosch University  http://scholar.sun.ac.za
9Figure 1-4  Immune responses to Tuberculosis (Kaufmann; 2010).
T cells and Macrophages are key cells in controlling M. tuberculosis, which survives inside the 
phagosomal compartment in macrophages and denritic cells. Exogenous mycobacterial peptides are 
presented to CD4 T cells in the context of MHC class II whereas mycobacterial antigens translocated 
into the cytosol, or cross-primed when macrophages release apoptotic bodies carrying
mycobacterial peptides, are loaded on MHC I and  presented to CD8 T-cell.  Th1 cells produce IL-2 for 
T-cell activation as well as IFN-g and TNF for macrophage activation. Th17 cells, which activate 
mainly neutrophils, contribute to the early formation of protective immunity in the lung after 
vaccination. Th2 cells produce IL-4 and regulatory T cells (Treg) TGF or IL-10 and counter-regulate 
Th1-mediated effects. CD8 T cells produce IFN-g and TNF, which activate macrophages and also 
secret perforin and granulysin which lyses target cells and attack M. tuberculosis.
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1.1.4.1 Macrophages
Macrophages are key cells in the immune response to M. tuberculosis by presenting 
antigens to T cells in the context of both MHC class I and II. The activated T cells in turn 
activate macrophages by secreting IFN-g to kill the bacteria  (Flynn and Chan; 2001).
Activated macrophages also secrete an important proinflammatory cytokine, TNF, which 
induces antimycobacterial effect in synergy with IFN-g (Bekker et al.; 2001). Furthermore, 
macrophages play an important role in recruitment of cells at the site of infection by 
secreting the proinflammatory cytokines IL-1 and IL-6 (Giacomini et al.; 2001).
Activated macrophages kill engulfed pathogenic bacteria via different mechanisms, 
including phagosome-lysosome fusion, generation of reactive nitrogen intermediates, 
particularly nitric oxide and generation of reactive oxygen intermediates. The maturation of 
phagosomes is a dynamic process where the phagosomes, which contain engulfed microbes 
fuse with lysosomes (Desjardins et al.; 1994; Desjardins; 1995). The phagolysosome fusion 
represents a major antimicrobial mechanism where engulfed microbes are degraded by 
intralysosomal acidic hydrolases (Flynn and Chan; 2001). 
M. tuberculosis prevents phagolysosomal fusion and survives inside macrophages 
(Armstrong and Hart; 1971; Hart et al.; 1972). However, how mycobacteria modulate the 
phagosomal membrane to block further maturation into phagolysosomes remains largely 
unknown. It has been reported that mycobacterial sulfatides, derivatives of multiacylated 
trehalose 2-sulfate, a lysosomotropic polyanionic glycolipid and ammonia have the ability to 
inhibit phagolysosomal fusion (Flynn and Chan; 2001).
Reactive Nitrogen Intermediates
Stellenbosch University  http://scholar.sun.ac.za
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Macrophages have been shown to produce nitric oxide (NO) and other reactive nitrogen 
intermediates (RNI) via the NOS2 enzyme using L-arginine as a substrate. NOS2 is induced by 
IFN-g and a second signal such as TNF-a or bacterial products such as LPS or LAM 
(MacMicking et al.; 1997). Nitric oxide production within macrophages has major anti-
microbial mechanisms. RNI can inflict damage to the bacterium by modifying DNA, proteins 
and lipids. In murine models, toxic nitrogen compounds have been shown to play a role in 
protection in both an acute and a chronic M. tuberculosis infection (Shiloh; 2000).
Reactive Oxygen Intermediates 
Unlike the role of NOS2, the importance of toxic oxygen species in the control of TB is not 
fully understood. Although ROI were shown to kill some species of mycobacteria like M. 
microti and H2O2 generated by cytokine activated macrophages was mycobacteriocidal, the 
effect of ROI on M. tuberculosis remains to be confirmed (Walker and Lowrie; 1981; Flesch 
and Kaufmann; 1987; Chan et al.; 1992). The mycobacterium cell wall component, LAM, 
scavenges and enables mycobacteria to escape the toxic effect of ROI (Chan et al.; 1989; 
Chan et al.; 1991). Tubercle bacilli also produce both superoxide dismutase and catalase 
that may interfere with toxic oxygen radical production. 
1.1.4.2  Dendritic cells
Dendritic Cells (DC) are superior antigen presenting cells (APCs) and they help in maximizing 
the recognition of antigens by T cells in the draining lymph nodes (Gonzalez-Juarrero et al.; 
2003; Flynn; 2004; Marino et al.; 2004). DC-SIGN is a receptor through which dendritic cells 
interact with microbes and its interaction with components of mycobacteria has been 
reported as one of the major examples how M. tuberculosis influence DC function (Tailleux 
et al.; 2003). The initiation of the immune response to limit infection during primary TB 
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occurs when immature DC capture M. tuberculosis, which leads to matured DC that migrate
into draining lymphnode, present and stimulate T cells (Sertl et al.; 1986). In this
compartment, T cells are activated, differentiate into effector and memory T cells and 
induce protection against M. tuberculosis in the lungs (Kaufmann; 2001; Kaufmann and 
Schaible; 2003).
1.1.4.3 T cells
M. tuberculosis is a classic example of a pathogen which resides intracellularly within 
macrophages and for which the protective response relies on cell-mediated immunity. 
Studies demonstrated that acquired immunity to M. tuberculosis requires contributions by 
multiple T cell subsets:  CD4 T cells, CD8 ab and gd T cells and CD1 restricted T cells (Boom 
et al.; 2003).
1.1.4.4 CD4 T Cells
CD4 T cells play a dominant role in the protective response against M. tuberculosis
(Kaufmann et al.; 2005). The mycobacteria reside within macrophage vacuoles; therefore, 
mycobacterial antigens are loaded on MHC class II and presented to CD4 T cells through 
endocytic antigen presentation pathway. Upon activation, CD4 T cells secret IFN-•, IL 2 and 
TNF, which in turn activates macrophages (Flynn and Chan; 2001). CD4 depleted or
disrupted mice and adoptive transfer of CD4 cells showed that this population is important 
for controlling infections (Orme and Collins; 1983; Orme and Collins; 1984; Muller et al.; 
1987; Tascon et al.; 1998; Caruso et al.; 1999). In humans, the necessity for CD4 T cells to 
help control of infection is shown by the rapid acceleration of TB in HIV positive patients 
who have loss of CD4 T cells (Selwyn PA; 1989). Moreover, CD4 cells are also important to 
enhance APC function through interaction of CD40-CD40L between CD4 T cells and APC and 
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this in turn can facilitate APC medicated induction of other T cells such as CD8 T cells 
(Andreasen et al.; 2000). 
Studies in CD4 depleted or deficient mice have also shown that CD4 cells have other roles in 
addition to IFN-g production in controlling mycobacterial infections (Scanga et al.; 2000).
CD4 T cells induce apoptosis through perforin and granulysin, FAS-L or TNF-a lytic pathways 
(Oddo et al.; 1998), provide help for B cells and CD8 T cells, and produce other cytokines
(Keane et al.; 1997), including those that limit immunopathology. 
1.1.4.5 CD8 T Cells
The MHC class I-restricted CD8 T cells contribute to protective immunity against TB 
(Kaufmann; 2006; Cooper; 2009) however, mechanisms underlying CD8 T cell stimulation 
are not fully understood. The stimulation of CD8 T cells requires mycobacterial peptide 
presentation by MHC I products, which generally occurs in the cytosol which is not readily 
accessed by M. tuberculosis. Two pathways have been proposed: first, M. tuberculosis can 
enter into the cytosol of infected DCs, and this leads to direct loading of MHC I molecules
(van der Wel et al.; 2007). Secondly, apoptosis of macrophages infected with M. tuberculosis 
results in mycobacterial antigen carrying vesicles, which are taken up by DCs and leads to
cross priming (Winau et al.; 2006). CD8 T cells that are specific for mycobacterial antigens 
can produce IFN-g and secrete perforin and granulysin, which lyse host cells and attack M.
tuberculosis directly (Stenger et al.; 1997).
1.1.4.6 Unconventional T cells
CD1 restricted CD4 and CD8 T cells and gd T cells participate in the response against M. 
tuberculosis in humans (Kaufmann; 1996; Lewinsohn et al.; 1998; Lewinsohn et al.; 2000). 
CD1 molecules present glycolipid antigens, which are found in the cell wall of mycobacteria. 
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These cells secrete IFN-g and express cytolytic activity (Porcelli and Modlin; 1999; Ulrichs 
and Porcelli; 2000). 
Studies in mice showed that gd T cells partially protect against high doses of M. tuberculosis
infection and they are important in regulating granuloma formation (Ladel et al.; 1995; 
D'Souza et al.; 1997). In humans, these cells comprise about 5% of the whole T cell 
population in peripheral blood (Kaufmann; 1996). The gd cells have a mycobacteriocidal 
activity via the release of their granules and stimulation of these cells with phospholigands 
also induces IFN-g production (Behr-Perst et al.; 1999). Therefore, these cells are believed to 
be part of the first line of defense against TB.
1.1.5 Cytokines
Cytokines are proteins, which play a role in disease protection, progression or development 
of pathophysiology. Different animal and human studies have firmly established that 
cytokines have a major role in determining the outcome of infection with M. tuberculosis.
Interferon-g (IFN g)
Conventional CD4 and CD8 T cells are considered as the primary source of IFN-g  and from 
mouse and human studies it is a well-established fact that IFN-g is a critical cytokine 
involved in the control of M. tuberculosis infection. Mice with a genetic deficiency of IFN-
g are very susceptible to infection with virulent M. tuberculosis with a shorter mean survival 
time and less NOS2 production, indicating that macrophage activation was defective, 
contributing to the susceptibility of IFN-g  gene knockout (KO) mice (Flynn et al.; 1993). The 
importance of this cytokine has also been confirmed in humans who have a mutation in 
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their IFN-g receptor genes, who display heightened susceptibility to mycobacterial infections 
(Jouanguy; 1999). 
IFN-g can also be produced by gd T cells, NKT cells and NK cells and both in vitro and in vivo 
studies showed that these cells can display protective effects against M. tuberculosis. 
However, the role of these cells in the presence of adaptive T cells is not clear and it is 
believed that these cells may serve as secondary sources of IFN-g at time of heavy or 
hypervirulent mycobacterial exposure (Cooper et al.; 2011).
Tumour Necrosis Factor a (TNF-a)
Tumor necrosis factor plays a central role in the initiation and maintenance of controlling M. 
tuberculosis by activating macrophages and facilitating granuloma formation (Flynn et al.; 
1995a; Schaible et al.; 1999; Dinarello; 2003). TNF-a, in synergy with IFN-g, activates
macrophages to produce RNI and mice deficient in TNF-a or the 55-kDa TNF receptor 
succumbed to infection (Flynn et al.; 1995a; Bean et al.; 1999). TNF-a or its receptor also 
affects cell migration and the granulomatous response following M. tuberculosis infection 
(Vaday et al.; 2001). In addition, reactivation of latent disease in rheumatoid arthritis 
patients after neutralization of TNF with specific monoclonal antibodies signifies the 
importance of this cytokine (Keane; 2005).
Interleukin 12 (IL-12)
A type 1 T cell response must be generated to control M. tuberculosis infection as is the case 
for most intracellular infections. The susceptibility of IL-12p40 gene deficient mice to M. 
tuberculosis and the therapeutic role of IL-12 strongly support an important role for this 
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cytokine in the protective immune response against M. tuberculosis (Flynn et al.; 1995b; 
Cooper et al.; 1997). In chronically M. tuberculosis infected mice administration of IL-12 DNA 
has been reported to reduce the bacterial load (Lowrie; 1999). Mutations in the IL-12p40 
receptor IL-12RB1 gene are also strongly associated with susceptibility to TB (Altare et al.; 
1998).
Interleukin 10 (IL-10)
IL-10 is an anti-inflammatory cytokine, possesses macrophage deactivating properties which 
in turn leads to down regulation of IL-12 and TNF and consequently IFN-g secretion by T cell 
and MØ activation (Turner et al.; 2002; Beamer et al.; 2008). Suppression of T cell 
proliferation in vitro by MØs isolated from human TB patients could be reversed by 
inhibition of IL-10 (Gong J-H; 1996). CD4 T cell responses and APC functions during
mycobacterium infection has been shown to be directly inhibited by IL-10 (Rojas et al.; 
1999). 
Tumour Growth Factor b (TGF-b)
TGF-b is a classic anti-inflammatory cytokine, which counteracts protective immunity 
against tuberculosis by inhibiting T cell proliferation and IFN-g production. It antagonizes 
antigen presentation, proinflammatory cytokine production, and cellular activation in 
macrophages by inhibiting IFN-g induced NOS2 production (Ding et al.; 1990; Hirsch et al.;
1997; Rojas et al.; 1999). During TB TGF-b is produced in excess and is expressed at the site 
of disease (Toossi; 1995). 
Interleukin 4 (IL-4)
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The role of IL-4 in TB is subject of some controversy. Increased production of IL-4 in mice 
infected with M. tuberculosis has been associated with progressive disease (Hernandez 
Pando and Larriva Sahd; 1996) and reactivation of latent infection (Howard; 1999) as IL-4 
suppresses IFN-g production, and macrophage activation (Lucey; 1996). Conversely, IL-4 KO 
mice displayed normal instead of decreased susceptibility to mycobacteria (North; 1998). 
Interleukin 17 (IL-17)
IL-17 is a relatively newly identified cytokine and it is important for recruiting neutrophils 
and repairing tissues and its role in the immune response against rapidly growing 
extracellular pathogens has been shown in different studies (Ye et al.; 2001a; Ye et al.; 
2001b; Happel et al.; 2005). The gd T cell population is a major source of early IL-17 during 
mycobacterial infection (Lockhart et al.; 2006; Umemura et al.; 2007). After low dose 
aerosol infection, the ability of mice to control M. tuberculosis is not significantly affected by 
the absence of IL-23, a DC derived inducer of IL-17 or IL-17 signaling (Khader et al.; 2005; 
Aujla et al.; 2007). However, mice deficient in IL-17 were unable to control M. tuberculosis
after high dose intratracheal infection (Okamoto Yoshida et al.; 2010). IL-17 is mainly 
associated with its crucial role in early granuloma formation and efficient mycobacterial 
killing via neutrophil recruitment and triggering proinflammatory programs associated with 
chemokine secretion (Seiler et al.; 2003; Silva; 2010).
1.1.6 Chemokines
Chemokines (chemotactic cytokines) are largely responsible for cell trafficking to the site of 
infection, however, their role in M. tuberculosis infection have been investigated to a 
limited extent. M. tuberculosis induces elevated levels of a variety of chemokines, including 
IL-8 (CXCL-8), monocyte chemoattractant protein 1 (MCP-1) (CCL-2), MCP-3 (CCL-7), MCP-5
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(CCL-12), Regulated on Activation Normal T Cell Expressed and Secreted (RANTES/CCL-5), 
Macrophage Inflammatory protein (MIP1)-a (CCL-3), MIP1-b (CCL-4), MIP-2 (CXCL-2), and 
IP-10 (CXCL-10) (Rhoades et al.; 1995; Orme and Cooper; 1999) and their receptor like CCR5 
and CXCR4 (Juffermans et al.; 2000).
1.2 Mycobacterium tuberculosis genetic diversity and its effect on immune 
responses
The sequencing of the complete genome of M tuberculosis in 1998 helps significantly in 
developing different genotyping methods to characterize strains according to their genome 
differences. Different molecular techniques have been used to characterize strain to strain 
variation in M. tuberculosis and studying molecular epidemiology of M. tuberculosis in 
different population assists in understanding their global distribution. The genome of  
M. tuberculosis is highly conserved compared with other pathogenic bacteria and it exhibits
no or very limited horizontal gene transfer. However, the presence of Single Nucleotide 
Polymorphism (SNP), deletions, insertions and/or repetitive elements has led to many
polymorphisms in the M. tuberculosis genome. M. tuberculosis isolates have been 
characterized to strain level by using different genetic markers which are specific in different 
clinical isolates (Bifani et al.; 2002). The genetic biomarkers include Spacer Oligonucleotide 
Types (spoligotypes), Mycobacterial Interspersed Repetitive Units-Variable Number Tandem 
Repeats (MIRU-VNTRs), IS6110 Restriction Fragment Length Polymorphisms (RFLP), Long 
Sequence Polymorphisms (LSPs) and Single Nucleotide Polymorphisms (SNPs) (Shabbeer et 
al.; 2011).
The global population structure of M. tuberculosis is defined by six phylogeographical 
lineages based on LSP: Indo-Oceanic lineage, East Asian lineage, East African-Indian lineage, 
Stellenbosch University  http://scholar.sun.ac.za
19
Euro-American lineage, West African lineage I and West African lineage II (Gagneux and 
Small; 2007). The Indo-Oceanic lineage (Lineage I), West African lineage I (Lineage 5) and 
West African lineage II (Lineage 6) are belonging to ancient lineages whereas the East Asian 
lineage (Lineage 2), East African-Indian lineage (Lineage 3) and Euro-American lineage
(Lineage 4) belong to the modern lieage (Gagneux et al.; 2006). The lineage names reflect 
particular geographical areas where each lineage is found most commonly and 
geographically structured (Figure 1-5). For example, India is dominated by the Indo-Oceanic 
lineage, the Far East by the East-Asian lineage and the Euro-American lineage is the 
dominant lineage in Europe and the Americas. In contrary to the other regions where a 
single lineage is more dominant, all six main lineages are represented in Africa. These 
lineages included both ancient and modern lineages (Gagneux et al.; 2006). 
Figure 1-5 Global phylogeography of MTBC (Gagneux; 2012). 
(a) Phylogeny of the six MTBC lineages (b) Distribution of the six MTBC lineages. Colored dots 
represent the major lineages in the respective countries
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The environmental and host factors are important elements affecting the outcome of
infection and disease presentation (Bellamy; 2005; Lonnroth et al.; 2009), however, the role 
of bacterial factors particularly strain-to-strain variation is not clearly understood. The 
existing dogma of rare allelic polymorphism in this organism compared with other bacteria, 
which leads to low levels of genetic variation in M. tuberculosis, has lead to the assumption 
that strain diversity would have no clinical significance. However, the application of the 
different genotyping methods and recent advances in mycobacterial genomics and 
population genetics show that the genomic variation in M. tuberculosis might have been 
underestimated, and that the different phenotypic characteristics of the pathogen may be 
associated with its genotype (Nicol and Wilkinson; 2008). 
Studies suggest that lineages differ in their natural history of infection, presentation of 
disease, immune response and response to treatment (Gagneux et al.; 2006; Caws et al.; 
2008; Thwaites et al.; 2008; Burman et al.; 2009; van der Spuy et al.; 2009). Gagneux and 
colleagues, recently showed that specific relationships between the genome of the host and 
genotype of the pathogen affects the ability of different lineages of M. tuberculosis to cause 
secondary cases (Gagneux et al.; 2006). Nahid and colleagues also showed that cavitary 
disease in participants from the African region caused by East Asian lineage isolates may be 
less responsive to combination therapy (Nahid et al.; 2010). Similarly, another study in 
South Africa reported a higher likelihood of treatment failure in patients infected by 
members of the Beijing family (van der Spuy et al.; 2009). Other studies reported an 
association between disease progression in tuberculosis meningitis and the East Asian 
lineage. The Euro-American lineage causes a limited extent of tuberculosis disease and are 
less able to cause disseminated or meningeal tuberculosis (Caws et al.; 2008; Thwaites et al.; 
2008).
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Beijing M. tuberculosis strains have shown marked virulence in animal models of infection 
(Mathema et al.; 2006) and it has been suggested that certain subgenotypes of Beijing may 
have increased transmissibility and/or pathogenicity (Hanekom et al.; 2007). Many reports 
from Germany, Italy, Russia, Estonia, South Africa and Columbia documented that the 
isolates identified as Beijing genotype were associated with multiple drug resistance 
(Caminero et al.; 2001; Drobniewski et al.; 2002; Filliol et al.; 2002; Lari et al.; 2004; Cowley 
et al.; 2008). Other studies have found Beijing strains to be associated with HIV (Middelkoop 
et al.; 2009). 
M. tuberculosis interferes with the host immune system in different ways (Flynn and Chan; 
2005). Several studies suggested that the genetic diversity of M. tuberculosis affects some 
characters of the pathogen where one genotype induces more proinflammatory cytokines 
whereas the other induces a higher level of anti-inflammatory cytokines. For example, Strain 
CDC1551 and Strain HN878 differ in virulence and this has been linked to their cell wall lipid 
components. Studies indicate that cytokines which are characteristic of a protective 
immune response including TNF-•, IL-1, IL-12, and IFN-g were upregulated in human 
monocytes and mice by CDC1551 or its lipid extracts (Manca et al.; 1999; Manca et al.; 
2004). 
On the other hand, increased production of macrophage deactivating cytokines such as  
IL-11 and IL-13 and reduced expression of proinflammatory cytokines such as IL-6, TNF and 
IL-12 has been associated with strain HN878 due to the production of a phenolic glycolipid 
(PGL). Production of type 1 interferon (a and b), which has been associated with decreased 
survival in mice, was observed in infection with strain HN878 (Manca et al.; 2001; Manca et 
al.; 2004). 
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Macrophages infected with strain CH of the East African-Indian lineage expressed and 
secreted less protective IL-12p40 and more regulatory IL-10. A high proportion (23%) of 
subjects infected with this strain had progressed to active disease within a year and the 
deletion of Rv1519 in this strain was taken as a reason why the innate immunity was 
diminished (Newton et al.; 2006). Another study conducted in Madagascar indicated that 
new or modern strains induced a host response different from that of ancient strains. In this 
longitudinal study they reported a lower IFN g response in TB cases infected with modern M. 
tuberculosis strains, like Beijing and Central Asian (CAS) strains than those infected with 
ancient strains like East African-Indian (EAI) strains.  They also found a similar result in 
household contacts according to the genotype of the strains isolated from their respective 
index cases (Rakotosamimanana et al.; 2010).  A study in The Gambia also showed an 
attenuated T-cell response to early secreted antigenic target 6 (ESAT6) in TB patients and 
their household contacts infected with West African lineage II (Rakotosamimanana et al.; 
2010).
1.3 Biomarkers of tuberculosis
The vigorous applications of the existing strategies and the coordinated efforts in the past 
years to control TB have had a positive effect on disease incidence, but the elimination of 
the disease is a log way off. Lack of effective vaccines, drugs, unavailability of simple 
diagnostic methods, spread of HIV/AIDS in TB-endemic regions and emergence of multidrug-
resistant (MDR) and extensively drug-resistant (XDR-TB) TB strains, makes all these efforts 
unfruitful.
This experience has led to more research on innovating simple and rapid diagnostic tests, 
new drugs and vaccines. The current widely used diagnostic technique, therapeutic drugs 
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and vaccines were licensed a very long time ago and are inefficient in detecting, treating or 
protecting against tuberculosis. The lack of reliable simple biomarkers to indicate or predict 
the different clinical outcomes of M. tuberculosis infection has been given as a key reason 
for the failure of developing new tools, drugs and vaccines against tuberculosis. 
A biological marker, or biomarker, is a characteristic that is objectively measured and 
evaluated as an indicator of a normal physiological or pathological process or 
pharmacological response(s) to a therapeutic intervention (Group; 2001).  Host or pathogen 
specific TB biomarkers provide prognostic information, either for individual patients or 
study cohorts, about future health status and can advance knowledge of disease 
pathogenesis in predicting reactivation and cure, and indicating vaccine-induced protection
(Figure 1-6). Biomarker studies use urine, saliva, breath and sputum samples to identify 
molecules for indicating or predicting the different clinical outcome of M. tuberculosis
infection, however, peripheral blood remains an attractive sample type due to the ease with 
which this sample can be obtained. Gene transcripts, proteins, lipids and metabolites can all 
be measured in blood for biomarker studies (Parida and Kaufmann; 2010).
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Figure 1-6 Host Biomarkers of Tuberculosis (Walzl et al.; 2011).
The different clinical outcomes of M. tuberculosis infection are determined by the different 
cells and molecules of both the innate and adaptive immune system. Infection with M. 
tuberculosis has different outcomes, which includes absence of any clinical or laboratory 
evidence of infection, latent infection and active disease. Application of a single or 
combination of markers could discriminate the different clinical groups.
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The century old sputum smear microscopy is the most widely used test in high endemic 
countries and this test is inadequate to diagnose early active TB disease and unable to 
diagnose extra-pulmonary TB, sputum smear-negative TB (active pulmonary TB with less 
than 10,000 bacilli per ml of sputum) and childhood TB. Studies have indicated that 
Interferon Gamma Release Assays (IGRAs) show stronger responses in people with active TB
than in those with latent TB (Janssens; 2007). Recent studies reported that IL-2, IFN-g (Casey 
et al.; 2010) and TNF-a expression profiles of CD4 T cells (Harari et al.; 2011) hold promise in 
detecting active TB disease. Polycytokine signatures including EGF, sCD40L, MIP-1•, VEGF, 
TGF-• or IL-1• were reported to differentiate active TB disease from latent TB (Chegou et 
al.; 2009). In addition, the RNA expression level of CXCL-8, FoxP3 and IL-12• differentiates
latent TB infection from disease (Wu et al.; 2007). Detection of circulating antibodies for 
diagnostic of prognostic potential are suggested in studies indicating correlation of M. 
tuberculosis-specific antibodies with bacterial burden (Kunnath-Velayudhan et al.; 2010).
Combined expression patterns of Fc gamma receptor 1B (FcgR1B), FcgR1A (CD64), RAB33A 
and lactoferrin (LTF) (Jacobsen et al.; 2007; Maertzdorf et al.; 2011) and RIN3, LY6G6D, 
TEX264, and C14orf2 (Mistry et al.; 2007) genes also showed a discriminating power 
between active TB and LTBI. 
Sputum culture or smear microscopy status after 2 months of therapy has been used as a 
surrogate marker for prediction of non-relapsing cure. The increased level of M. tuberculosis
antigen 85 and 85B RNA in sputum protein during the first week of treatment predicted 
relapse or failure (Wallis et al.; 1998). Levels of IFN-g (Chee et al.; 2010), IL-10, the ratio of 
IFN- g/IL-10 (Sai Priya et al.; 2010) and IL-4/IL-4•2 (Wassie et al.; 2008) have been reported 
to have an association with treatment outcome. There are also other molecules which 
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decrease after treatment, like soluble intercellular adhesion molecule (sICAM)-1 (Lai et al.; 
1993; Mukae et al.; 2003; Walzl et al.; 2008), C-reactive protein (Plit et al.; 1998) soluble 
urokinase plasminogen activator receptor (Eugen-Olsen et al.; 2002) and procalcitonin
(Baylan et al.; 2006; Prat et al.; 2006).
High or increasing concentrations of TB specific IFN-g production might predict overt TB
(Doherty et al.; 2002; Higuchi et al.; 2008). The relative mRNA levels of IFN-g, IL-4, and IL-
4•2 have been reported as a better marker than IFN-g alone, since ratios of IFN-g to IL-4 
and IL-4•2 to IL 4 decreased when contacts developed TB and increased in cured TB cases  
(Siawaya et al.; 2008; Wassie et al.; 2008). In chronic or long term latently infected 
individuals, the ration of IL-4 to IL-4•2 is also decreased, probably showing low risk for
reactivation (Demissie et al.; 2004). Health-care workers who were heavily exposed to TB
showed intermediate concentrations of neopterin, potentially indicating risk of reactivation 
of latent M. tuberculosis infection (Ozdemir et al.; 2006).
While a number of biomarkers have been found to be associated with TB protection or TB 
disease, there are no qualified biomarkers to indicate protection by new vaccines against 
TB. IFN-g has been used as a biomarker of protection; however, it is not a reliable biomarker 
of protection though it is an important component of the immune response. Expression of 
the cytokine may rather be a marker of the magnitude of the inflammatory response
(Mittrucker et al.; 2007). Currently, polyfunctional T cells expressing multiple cytokines (IL-2, 
TNF-a and IFN-g) are being increasingly studied; however Kagina et al. recently reported 
that the specific CD4 T cell response 10 weeks after BCG vaccination in newborns do not 
correlate with ultimate risk of TB disease. Moreover, risk of disease during the first 2 years 
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of life was not associated with mono or polyfunctional or CD8 T cells in newborns (Kagina et 
al.; 2010).
In summary, there is no consensus biomarker(s), which predict protection or progression to 
disease. Although considerable evidence exists that IFN-g is involved in immunity, 
expression of this marker alone has little predictive value. While disease associations with 
other biomarkers or biomarker combinations have been reported, results have been 
inconsistent across laboratories, underscoring the need for more research.
1.4  Vaccination strategies against tuberculosis
The current vaccine against TB, Bacillus Calmette-Guérin (BCG) vaccine, which was 
developed between 1906 and 1919 without any immunological correlation by attenuation 
of the virulent Mycobacterium bovis, has been given 4 billion times over the last 90 years 
(Kaufmann; 2010). BCG is given as part of the expanded program of immunization and has 
an excellent safety record, is inexpensive and has proven protective efficacy against severe 
childhood forms of the disease, against meningitis and military TB and to a lesser extent 
against lung TB in infants. It is, however, not effective against pulmonary TB in adults, which 
is the most prevalent form of the disease. Moreover, in HIV infected infants the risk of 
disseminated BCG disease is significantly higher (Bricks; 2004). This failure of protection and 
risk of disseminated BCG in HIV infected children underscore the need for novel improved 
vaccination concepts towards safe vaccines against newborn and adult TB in HIV negative or 
positive individuals.
Considering the global TB epidemiology, TB vaccination strategies follow two different 
approaches: pre-exposure vaccination in order to prevent disease in individuals who have so 
far not encountered M. tuberculosis versus post-exposure vaccination that aims at inhibiting 
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disease outbreak in individuals that are already infected (Figure 1-7) (Kaufmann et al.; 
2010).
Figure 1-7 Different vaccine strategies (Kaufmann; 2010).
(A) BCG vaccination at birth or pre exposure. (B) BCG prime and pre-exposure boost in children ; (C) 
Early childhood BCG prime and post-exposure boost in adults; (D) BCG replacement with better 
vaccine and pre-exposure vaccination at early age; (E) Active tuberculosis cases therapeutic 
vaccination; (F) BCG replacement vaccine at pre exposure and boost with another subunit vaccine at 
pre and post exposure; (G) BCG replacement vaccine at pre exposure and boost with another 
subunit vaccine at post exposure; and (H) pre-exposure and booster vaccination vaccination to 
prevent stable infection with M. tuberculosis.
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The first category follows the approach to improve the current BCG vaccine through 
recombinant (r) BCG strain constructs with improved vaccine efficacy that are intended to 
replace BCG. The two major representatives of this group are rBCG30, which is a BCG strain 
over-expressing the immunodominant M. tuberculosis antigen 85B, and rBCG•UreC:Hly 
(VPM1002), which is a recombinant strain that is deficient in urease and expresses 
listeriolysin produced by Listeria monocytogenes (Grode et al.; 2005; Tullius et al.; 2008). 
This vaccine facilitates the presentation of antigen to CD8 T cells in the context of MHC class 
I by translocating M. tuberculosis antigen into the cytoplasm via perforating the phagosomal 
membrane with the help of the acidic phagosomal pH due to deficiency of urase. Another 
viable vaccine candidate engineered with a similar approach introduces pore-forming 
capacities into BCG with perfringolysin (pfo) from Clostridium perfringens and expresses 
antigens Ag85A, Ag85B, and TB10.4 (Sun et al.; 2009).
In contrast, the second category of vaccine candidates is considered more for heterologous
prime-boost strategies, with BCG or rBCG as the prime vaccine. The first subgroup includes 
viral vectors that express immunodominant M. tuberculosis antigens for the initiation of 
strong Th1-dominated immune response to the expressed heterologous antigen and also 
induce CD8 T-cell responses. Currently two viral vectors are exploited for TB vaccines: 
modified vaccinia virus Ankara (MVA) developed by Oxford University and replication-
deficient adenovirus (Ad) of serotype 5 or 35 (Ad5 created by McMaster University and 
Ad35 created by Crucell and Aeras) with the advantage of a strong lung tropism that leads 
to an increased expression of immunodominant antigens at the site of mycobacterial entry. 
The MVA and Ad5 virus carriers were both engineered to express Ag85A whereas the Ad35 
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co-expresses the antigens Ag85A, Ag85B, and TB10.4. Pre-existing antibodies to adenovirus 
from frequent natural infections could impair Ad-based vaccine efficacy (Kaufmann; 2010).
Fusion proteins of immunodominant antigens with the aim of mounting strong immune 
responses against immunologically important M. tuberculosis antigens are also used as a 
heterologous prime-boost strategy. To ensure immunogenicity, recombinant protein 
vaccines need an adjuvant that promotes Th1 immune responses. Three different types of 
adjuvants are currently used for protein vaccines. Hybrid1 (H1) which is a fusion of the 
antigens 85B and ESAT-6 or HyVac4/AERAS-404, which is a fusion protein of Ag85B and 
TB10.4 (Dietrich et al.; 2005; van Dissel et al.; 2010) has been used in combination with an
adjuvant IC31 developed by Intercell. In the M72 vaccine, the antigens Rv1196 and Rv0125, 
are supplemented with adjuvants AS01 or AS02 (Von Eschen et al.; 2009). The inactivated 
mycobacteria M. vaccae, an environmental mycobacterium, and the semi-purified M. 
tuberculosis fragments RUTI are considered as therapeutic vaccinations that could 
potentially synergize with chemotherapy (Vilaplana et al.; 2010; von Reyn et al.; 2010). M. 
vaccae is a whole-cell vaccine thought to mount a protective immune response by providing 
cross-reactive antigens. RUTI comprises detoxified and fragmented M. tuberculosis 
components carried in liposomes. 
On top of the aforementioned vaccines which are already in clinical trials, there are also 
other future strategies which aim to induce long-lasting memory T cell responses comprising 
mostly CD4 Th1 cells that resist exhaustion, suppression, and deviation. This strategy targets 
CD4 cells to remain in a stage of alertness, whereby immune mechanisms can be promptly 
mobilized after encounter with M. tuberculosis or vaccines that achieve sterile eradication 
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of the pathogen in latently infected individuals or protect naive individuals by rapid 
elimination of M. tuberculosis after infection (Kaufmann; 2010). 
1.5 Significance of the study
Tuberculosis continues to be a major global health problem, causing an estimated 8.8 
million new cases and 1.45 million deaths annually despite the availability of a vaccine and 
inexpensive, effective, and reasonably well-tolerated therapy. Although WHO declared TB as 
a global emergency in 1993 and a number of efforts have been in place, the situation did 
not change significantly and TB remains the second most important killer disease next to 
HIV/AIDS. We are still using very old diagnostic techniques particularly in developing 
countries where the disease burden is high, old drugs with 6 month of therapy, which makes 
adherence challenging and a vaccine, which is not at all protective in some parts of the 
world.
The United Nations and the Stop TB Partnership aimed to decrease TB prevalence by half in 
2015 as compared to 1990 and to lower the incidence of new cases to less than 1 per million 
by 2050 (Dye and Williams; 2008). Albeit the TB prevalence is decreasing globally, it is 
unlikely any of these targets will be reached with the available diagnostic, therapeutic and 
preventive methods. Therefore, it is essential to develop better diagnostic tools, new drugs 
for active cases and latently infected individuals and vaccines for latently infected and 
uninfected individuals as well as HIV positive newborns. 
A recent mathematical model prediction showed that In 2050 TB incidence shall be reduced 
up to 71% if new vaccines, drugs and diagnostic tools are developed and introduced with a 
potential of each to reduce TB incidence by 39-52%, 10-27% and 13-42% respectively (Abu-
Raddad LJ et al.; 2009). It has been also postulated that the incidence of TB could be 
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reduced up to 94% in 2050 and the 2050 target could be reached by applying mass 
vaccination and introducing new diagnostic tools (Kaufmann et al.; 2010) . 
Therefore, in order to achieve the very ambitious targets of the Millennium Development 
Goals and curb the current TB problem, explorative studies on transcriptomic, proteomic 
and immunologic profiling, which could provide clues for developing new diagnostic tools, 
therapeutics and vaccines are more critical than ever before and will have a significant 
impact on the global tuberculosis problem. These exploratory studies would help in
identifying and developing simple, affordable and rapid methods for detecting active cases, 
discriminating between and diagnosing active tuberculosis disease and latent tuberculosis
infection and identifying persons most likely to progress to active disease and relapse after 
treatment. This is particularly true for developing countries where the incidence of active 
and latent tuberculosis is high and where smear microscopy is the only technique widely 
used for active case detection.  A reliable test for latent infection would be valuable to guide 
interventions in those most likely to progress to active TB, including HIV infected people and 
young children.  
Moreover, understanding the genetic diversity of M. tuberculosis strains is also an 
important component in designing new tools as some studies showed that strain differences 
affect effectiveness of drugs and vaccines and cytokine responses induced during infection 
of human macrophages. 
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1.6. Hypothesis
We hypothesized that in TB cases and their contacts there will be:
a) Discriminatory transcriptional signatures of immune response genes. Combinations 
of multiple genes could potentially distinguish TB cases and their contacts and the 
different clinical outcomes of M. tuberculosis infection.
b) Different plasma cytokine levels in TB cases and their contacts. Combination of the 
different cytokines could be potential biomarkers for discriminating TB cases and 
their contacts. HIV co-infection could affect the plasma level of these cytokines. 
These plasma levels of cytokines in TB cases will also be affected by anti tuberculosis 
treatment and will be similar to patterns in contacts after completion of treatment. 
c) Both ‘modern’ and ‘ancient’ genotypes of M. tuberculosis isolates are found in Addis 
Ababa as historical evidence showed that TB may have originated in the region and 
their proportion could be similar to that observed in other countries in the region 
and 
d) The genotype of M. tuberculosis will affect the plasma cytokines patterns in TB 
patients infected with different strains.
1.7 Aims
The main objectives of this study are:
· To study selected transcriptional signatures of different genes in whole blood in 
tuberculosis patients and healthy household contacts with Multiplex Ligation
Dependent Probe Amplification (MLPA) and to identify genes or combination of 
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genes which have discriminatory potential between TB cases and their contacts and 
between latently infected and uninfected contacts;
· To determine the plasma levels of cytokines in TB cases and their contacts and 
identify cytokines or combination of cytokines which have a discriminatory potential 
and could be used as biomarkers in differentiating between TB cases and their 
contacts and between latently infected and uninfected individuals;
· To characterize the genotypes of M. tuberculosis isolates which are circulating in 
Addis Ababa, Ethiopia;
· To determine the effect of infecting M. tuberculosis strains on the plasma level of 
cytokines in tuberculosis patients.
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CHAPTER 2
2. Materials and Methods
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2.1 Study Area
The study was conducted in Addis Ababa, Ethiopia. Ethiopia is a country located in the horn 
of Africa. It is the second-most populous nation in Africa, with over 82 million inhabitants, 
and the tenth largest by area, occupying 1,100,000 km2. Ethiopia is bordered by Eritrea to 
the north, Djibouti and Somalia to the east, Sudan and South Sudan to the west, and Kenya 
to the south. It is also the most populous landlocked nation in the world. Addis Ababa is the 
capital city of Ethiopia and often referred to as "the political capital of Africa", due to its 
historical, diplomatic and political significance for the continent. The city lies at an altitude 
of 7,546 feet (2,300 metres) and is located at 9°1•48•N 38°44•24•E. Addis Ababa has 
a subtropical highland climate. The city possesses a complex mix of highland climate zones, 
with temperature differences of up to 10 °C. According to the 2007 census conducted by the 
Central Statistical Agency of Ethiopia, the city has a total population of 2,739,551 of whom 
1,305,387 are men and 1,434,164 are women (Ethiopia; 2007). The study was conducted in 
four selected health centres that fall under the administration of the Addis Ababa Health 
Bureau: Arada, T/Haimanot, Kirkos and W-23 health centres.
2.2 Study Design and Study Period
The study was cross-sectional, conducted between March 2009 and December 2010 among 
newly diagnosed TB patients who presented to the health clinics and their contacts living in 
Addis Ababa, the capital city of Ethiopia, where the incidence rate of TB is high and BCG 
vaccination is routinely administered at birth. A longitudinal study was conducted on a 
subgroup of the TB cases.
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2.3 Study Population
The study population comprised two groups of study participants from the catchment areas 
of selected health centres who were recruited based on the presence or absence of active 
tuberculosis infection. The study population consists of male and female new index 
pulmonary TB patients and their household contacts aged between 18-60 years.
Index Cases (ICs)
Any tuberculosis suspect case attending the health centres for symptoms (including 
persistent cough, fever, haemoptysis, night sweating) suggestive of pulmonary tuberculosis 
and diagnosed by sputum smear examination (AFB positive in at least 2 out of 3 spot-
morning-spot sputum samples). 
Household contacts
These were apparently clinically healthy contacts of index cases living under the same roof 
of the index case for at least two weeks in the period of 3 months prior to tuberculosis 
diagnosis of the index case. 
2.4 Laboratory Methods
2.4.1 Blood Collection 
Twenty ml of venous blood was drawn from all eligible participants, where about 3 ml of 
venous blood was drawn into QuantiFERON tubes (Cellestis, Australia), 2.5 ml into PAXgene 
blood RNA tubes (PreAnalytiX, QIAGEN, Germany) and the rest of the blood into sodium 
heparin tubes for isolation of plasma and peripheral blood mononuclear cells (PBMCs). After 
collection, all blood specimens were transported to the AHRI laboratory at ambient 
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temperature and kept at room temperature for no more than 2 hours until processing,
except for QuantiFERON tubes, which were incubated at 37oC immediately upon arrival.
Plasma was collected from blood collected in heparinized tubes by centrifuging for 5 min at 
1000 RPM, aliquoted and stored at -80°C until cytokine determination. 
2.4.2 Quantiferon Gold In Tube (QFT- GIT) TB test
IFN-g responses to M. tuberculosis specific antigens were measured by the QFT assay, as per 
the manufacturer’s instructions, (http://www.cellestis.com). Three ml venous blood was 
directly collected into three 1-ml QuantiFERON-TB Gold In Tube (QFT-GIT) tubes (Cellestis, 
Victoria, Australia); one tube containing only heparin, a negative control (Nil), another tube 
containing phytohaemagglutinin (PHA), a positive control (Mitogen) and the third tube 
containing overlapping peptides representing the entire sequences of ESAT-6, CFP-10 and 
TB7.7  (TB Antigen). The tubes were shaken vigorously and then incubated at 37°C for 
approximately 20 hours. After 20 hours of incubation, the tubes were centrifuged and 
plasma was harvested and frozen at -20 C until the ELISA was performed. The level of IFN-
g was measured using the QFT ELISA kit (Cellestis, Victoria, Australia). The ELISA readout and 
data interpretation was carried out using the QFT software (Version 2.50, Cellestis, 
Australia. As recommended by the manufacturer, a positive test for TB infection was 
considered if the IFN-g difference was >0.35 IU/ ml (TB antigens -Negative control). The 
result of the test was considered indeterminate if an antigen-stimulated sample was < 0.35 
IU/ml (TB antigens-Negative control) plus if the value of the positive control was less than 
0.5 IU/ml (Positive control-Negative control).
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2.4.3 Multiplex Cytokine analysis
We used a 17plex kit (Epidermal Growth Factor (EGF), FRACTALKINE, Granulocyte 
Macrophage Colony Stimulating Factor (GM CSF), IFN-g, IL-1, IL 10, IL-12, IL-17, IL-4, IL-7, IL-
9, IFN-g inducible protein (IP-10 /CXCL-10), Macrophage Chemoattractant Protein 1 (MCP-
1/CXCL), MCP-3, Monocyte Inflammatory Protein 1 beta (MIP-1b), TNF and VEGF) from 
Millipore, Germany and multicytokine analysis was done using Luminex (Millipore, 
Germany) technology. Cytokines that have been associated with active TB disease or 
protection against disease in literature were included in the study. The principle of the 
technique is based on colour coded microspheres where combining different ratios of two 
dyes can give up to 100 different combinations, which enables the measurement of up to
100 analytes. The technology combines flow cytometric and ELISA principles. Capture 
antibody is conjugated with beads or microspheres whereas the secondary antibody is 
conjugated with a flurochrome, which quantifies the antigen-antibody reaction by 
measuring the relative fluorescence intensity. The assays were performed according to the 
supplier instruction. Briefly, following pre wetting of plates, 50 ml precombined beads of all 
the 17 individual anti-cytokines or anti-chemokines antibodies were added and washed 
twice. Plasma samples (25ml) were diluted 1:1 with the kit serum matrix and added to the 
plate. The plate was shaken for 30 sec at 1000 RPM and then incubated for 1 hour on a plate 
shaker at 300 RPM at room temperature. Plates were washed twice and 25ul of detection 
antibody was added per well and incubated for one hour on a plate shaker. Fifty micro litre
of a strepatavidin-PE conjugate was added per well and incubated for 30 min at room 
temperature. Finally, plates were washed three times and 150 microliter of sheath fluid was 
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added to each well and then the plate was read on a Luminex machine and data was 
analysed by Luminex 100 IS software version 2.3.182.
2.4.4 RNA Extraction
RNA extraction was performed following the manufacturer’s instructions (PAXgene Blood 
RNA Kit, PreAnalytiX, QIAGEN)(http://www.mlpa.com). Briefly, blood containing tubes were 
centrifuged at 3000 rpm for 10 min, supernatant discarded, pellets lysed and washed, 
followed by treatment with proteinase K and ethanol precipitation. To remove 
contaminating DNA, the analyte was further digested with RNase-free DNase (QIAGEN, 
Germany), washed and finally the RNA was eluted with RNase-free water, concentrations
quantified using GeneQuant spectrophotometer (Amersham Biosciences, UK) and stored at 
-80oC until use.
2.4.5 Multiplex Ligation-dependent Probe Amplification
Multiplex Ligation-dependent Probe Amplification (MLPA) was done according to the 
manufacturer instruction (http://www.preanalytix.com). The principle of MLPA follows
cDNA synthesis from mRNA and denaturation; hybridization of probes with the target 
genes; ligation of the two separate probes; PCR amplification; separation of the PCR product
and data analysis (Figure 2-1). First, the cDNA is synthesised from RNA by using RT primer 
mix and cDNA denatured and incubated overnight with the mixture of customized probes to 
allow the probes to hybridize with the target genes. Once the probes are hybridized with 
the target genes, the two separate probes are fused together using a ligase enzyme. The 
target genes, which were hybridized with the probes, are amplified. Finally the PCR product 
is separated by electrophoresis and the data analysed by measuring the fluorescence 
intensity.
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Figure 2-1 Multiplex Ligation dependent Probe Amplification (Joosten 2012).
RNA samples are reverse transcribed to cDNA with Reverse transcriptase (RT) enzyme. Denatured 
genomic cDNA is hybridized with a mixture of probes. Each MLPA probe consists of two 
oligonucleotides. The two parts of each probe hybridize to adjacent target sequence on the cDNA. 
The two parts of hybridized probes are ligated by a thermostable ligase. All probe ligations are
amplified by PCR using two different primer pairs, each labelled with a different fluorophore. The 
amplification product of each probe has a unique length. Amplification products are separated by 
electrophoresis. Relative amounts of probe amplification products reflect the relative copy number 
of target sequences.
A probe set has been designed for the GC 6-74 project by the Leiden University Medical 
Centre (LUMC), Leiden, The Netherlands and this set of probes contains forty five genes 
targeting immune cell subset markers, T reg markers, effector T cell markers and apoptosis 
related genes and four housekeeping genes. Genes that have been associated with active TB 
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disease or protection against disease in literature were included in the study. The list of 
genes for which a set of probe has been designed and studied for the GC 6 project is shown 
in table 2-1.
Table 2-1 List of target genes for Multiplex Ligation-dependent Probe Amplification
(MLPA)
Bcl2
BLR1(CXCR5)
BPI
CASP8
CCL4
CCL13
CCL19
CCL22
CCR7
CD3•
CD4
CD8•
CD14
CD19
CD163
CTLA4 (CD152)
CXCL10 (IP-10)
FASLG
Fc•R1A (CD64)
FOXP3
FPR1
IFN •
IL-2R• (CD25)
IL-4
IL-4•2
IL-7R (CD127)
IL-10
IL-22RA1
LAG3
LTF
MARCO
MMP9
NCAM1 (CD56)
RAB13
RAB24
RAB33
ASEC14-like 1
SPP1
TGF•1
TGF•-RII
TNF
TNFRSF1A
TNFRSF1B
TIMP2
TNFRSF18 (GITR)
Reference genes 
ABR, •2M, GAPDH, 
GUSB 
Multiplex ligation-dependent probe amplification was performed following the instructions
provided by MRC Holland, Amsterdam, The Netherlands (http://www.mlpa.com). Briefly, 
2.5 ml RNA sample mixed with 1 ml MMLV buffer plus 1 ml RT primer mix was heated at 80 
for 1 minute and then incubated at 45°C for 5 minutes.  While the mix was in the 
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thermocycler, the temperature was lowered to 37°C and 1.5 ml of MMLV reverse 
transcriptase was added and incubated for 15 minute. The reverse transcriptase was 
inactivated by heating to 98°C for 2 minutes and then after cooling to room temperature 
mixed with 3 ml of probe mix (containing 1.5 ml of each probe) and 1.5 ml of SALSA 
hybridization buffer, denatured at 95°C for 1 min and hybridized at 60°C for 16 h. Hybridized 
probes were ligated at 54°C for 15 min by addition of 32 ml ligation mixture (3 ml ligase 65 
buffer A, 3 ml ligase 65 buffer B, 1 ml of 65 ligase and 25 ml water). Following heat 
inactivation at 98°C for 5 min, 5 ml of ligation reaction was mixed with 20 ml of PCR master 
mix (2 ml SALSA PCR buffer, 1 ml SALSA enzyme dilution buffer, 1 ml SALSA PCR primers 
MLPA, 2 ml LUMC PCR primers MAPH, 0.25 ml SALSA polymerase and 13.75 ml water) and 
was subjected to PCR amplification for 33 cycles (30 s at 95°C, 30 s at 58°C, and 1 min at 
72°C) and ended with 20 minutes incubation at 72°C. A negative control (without RNA), a 
positive control (using synthetic template oligonucleotides as hybridization templates) and a 
commercial Human Universal Reference RNA were included on each run.
After completion of the MLPA reaction, amplified products were analysed with an ABI-310 
capillary sequencer in GeneScan mode (Applied Biosystems). The data from the sequencer 
were analysed using the GeneMapper software. Further analysis was done using Microsoft 
Excel spread sheet software. Finally data was normalised by selecting one of the 
housekeeping genes, which most stably expressed across the evaluated samples (ABR, 
GUSB, GAPDH or B2M). The coefficient of variation was calculated to determine which 
reference gene was most stably expressed across the evaluated samples. A peak area of 200
for signals was assigned as threshold value for noise cut off in GeneMapper. The relative 
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peak size of the product from the probe recognition sequence was compared with the 
relative peak size of the product from a control.
2.4.6 Mycobacteria Culture and DNA extraction
Two sputum samples were collected from each participant and pooled together for culture. 
An equal volume of 4% NaOH was added and shaken using an automatic shaker for 15min. 
The supernatant was decanted after centrifuging at 3000rpm for 15 min. One to two drops 
of phenol red indicator was added and then neutralized by using 2N HCL by adding drop by 
drop and shaken continuously until the colour changed from red to yellow. Once the 
sputum sample was decontaminated and neutralized, 100 µl was inoculated on Loewenstein 
Jensen media. The inoculated cultures were incubated in a slant position for one week at 37 
oC and then turned upright in the second week and followed up for growth over a period of 
8 weeks. Cultures with no growth after the eighth week were considered negative. 
Mycobacterial genomic DNA was isolated by heating the isolates at 80°C for 60 min and was 
stored at -20°C until it was subjected to spoligotyping.
2.4.7 Deletion Typing
Isolates were confirmed as M. tuberculosis by deletion typing of the RD9 region according to 
a previously described PCR protocol (Brosch et al.; 2002b). The status of the RD9 region 
(deleted or intact) was assessed by multiplex PCR with a set of three primers (primer set 
RD9): two primers targeting the flanking regions of RD9 (RD9_Fw, 5’- AAC ACG GTC ACG TTG 
TCG TG -3’, RD9_Rev, 5’- CAA ACC AGC AGC TGT CGT TG -3’and one primer hybridizing with 
the internal region of RD9 (RD9_IntRev, 5’- TTG CTT CCC CGG TTC GTC TG -3’. A PCR product 
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of 396 bp interpreted as that RD9 is present (i.e. M. tuberculosis) or 707 bp (RD9 deleted i.e.  
M. africanum and M. bovis) was identified by agarose gel electrophoresis (Figure 2-2).
The PCR mixture used for RD contained 2 •l of heat-killed mycobacterial DNA, a final 
concentration of 10 ml HotStartTaq master mix (Qiagen), 0.3 ml primers RD9_FW, RD9_Rev, 
and RD9_IntRev (100 µM), and 7.1 µl sterile distilled water to a final volume of 20 •l.
Thermal cycling was performed with T-3000 Thermocycler Biometra Amplifier (Biometra, 
Göttingen, Germany) with an initial denaturation step of 15 min at 96°C, 35 cycles of 30 s at 
96°C, 30 s at 55°C, and 1 min at 72°C, followed by a final elongation step of 10 min at 72°C. 
PCR products were separated on a 1% agarose gel.
Figure 2-2 Deletion typing of the RD9 region in the genome of M. tuberculosis and M. 
bovis, respectively.
In case of M. tuberculosis, RD9-Ff and RD9Int will amplify a product size of 1.5Kbp due to the 
presence pf RD9; whereas in case of M. bovis since RD9 is deleted, RD9Ff and RD9Fr will amplify a 
product size of 472Bpb.
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2.4.8 Spoligotyping
Spoligotyping is a PCR based molecular technique based on DNA polymorphism at the 
genomic Direct Repeat (DR) locus of Mycobacterium tuberculosis complex. The direct repeat 
locus consists of a repeated 36 base pair sequences and are separated by non-repetitive 35-
41 base pair length DNA spacers (figure 2-3). Although there are about 94 different spacers 
in the M. tuberculosis complex, only the originally described 43 spacers are used routinely 
for the classification of strains. One DR and its neighboring spacer are termed a “Direct 
Variant Repeat” (DVR). It was observed that the order of the spacers is about the same 
between clinical isolates, although the DR region has been shown to be polymorphic in 
different clinical isolates of M. tuberculosis. There are one or more IS6110 elements in most 
strains of M. tuberculosis in the DR region.
Figure 2-3  Structure of the DR locus in the genome of M. tuberculosis H37Rv and M. bovis
BCG. The green rectangles depict the 36 bp Direct Repeat (DR).
Spoligotyping was carried out using the commercially available kit from Ocimum 
Biosolutions, India, according to the manufacturer’s instructions (Kamerbeek et al.; 1997b) .  
Briefly, the direct-repeat (DR) region was amplified with primers DRa (50-GGT TTT GGG TCT 
GAC GAC-30 biotinylated at the 5’ end) and DRb (50-CCG AGA GGG GAC GGA AAC-30). PCR 
amplification was done for 53 cycles with denaturation, and annealing extension for 1min at 
95 0c and 55 0c respectively and extension for 30 sec at 720c in each cycle (figure 2-4). The 
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amplified DNA was hybridized to inter-DR spacer oligonucleotides covalently bound to a 
membrane. Sterile water and DNA from M. tuberculosis and M. bovis were used as negative 
and positive controls respectively. The amplified DNA was subsequently hybridized to a set 
of 43 oligonucleotide probes by reverse line blotting. The hybridized PCR products were 
incubated with streptavidin-peroxidase conjugate, and signal detection was obtained with 
an enhanced chemiluminescence detection system (Amersham, Little Chalfont, England), 
followed by exposure to X-ray film (Hyperfilm ECL; Amersham) according to the 
manufacturer’s instructions. The X-ray film was developed and washed using standard 
photochemical procedures.
Figure 2-4 Principle of DNA amplification of the DR region of M. tuberculosis complex 
bacteria.
The two primers, a and b will lead to the amplification of any spacer or a stretch of 
neighboring spacers and DR’s.
2.4.9 Database comparison
A Microsoft Excel sheet was prepared and the spoligotyping results were entered manually 
in binary format and then the binary format was converted into octal form. The black and 
white squares in the spoligopattern represent the presence and absence of individual 
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spacers respectively. The spoligopatterns, which were prepared in binary and octal formats 
were entered and determined by comparing the spoligotyping results with already existing 
designations in the international spoligotyping database, SpolDB4.0 (Brudey et al.; 2006)
(http://www.pasteur-guadeloupe.fr:8081/SITVITDemo). In this database, shared types (ST)  
designates spoligotypes shared by two or more strains having identical spoligopattern 
whereas single patterns which do not have a match in the database are designated as 
Orphans. There are 62 lineages and sub lineages defined in the SPOIDB4 database specific 
for the members of M. tuberculosis complex species. Currently, the SpoIDB4 database has a 
collection of about 39, 609 spoligopatterns from 121 countries all over the world. Families 
and subfamilies were assigned for patterns that were not found in SpoIDB4.0 data base 
using SpotClust program (http://cgi2.cs.rpi.edu/_bennek/SPOTCLUST.html) (Vitol et al.; 
2006). 
2.5 Ethical considerations
The study protocol was approved by the AHRI/ALERT (P015/10) and National Ethical Review 
Committees (3.17/17/03). Written informed consent was obtained from all study 
participants. The informed consent described the purpose of the study, the procedures to 
be followed, and the risks and benefits of participation. All records were kept in a secured 
place and copy of the consent was given to all participants.  
2.6 Statistical Analysis
The data were analyzed using Graph pad prism software, version 4.0 for Windows,
GraphPad Software, San Diego California USA, and STATISTICA software, version 10. 
Nonparametric Mann–Whitney U tests were performed to find the significance of the 
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observed differences between the different groups. STATISTICA multivariate analysis for 
General Discriminant Analysis (GDA) and Receiver Operator Characteristic (ROC) curve were 
used to evaluate the predictive abilities of combinations of biomarkers and generate cut off 
values for differentiating between M. tuberculosis infection states. The GDA is a multivariate 
analysis of variance hypothesis of the test that two or more groups (conditions, levels) differ 
significantly on a combination of discriminating variables whereas ROC, or ROC curve, is a 
graphical plot which illustrates the performance of a binary classifier by plotting the fraction 
of true positives out of the positives (Sensitivity) vs the fraction of false positives out of the 
negatives (one minus the specificity). A P value less than 0.05 was considered as statistically 
significant.
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CHAPTER 3
3. Expression of immune response genes from whole blood 
discriminate the different clinical tuberculosis groups in Ethiopian 
cohorts
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Abstract
Background: Genetic factors are involved in susceptibility to tuberculosis. Apart from gene 
polymorphisms and mutations, changes in levels of gene expression, induced by non-genetic 
factors, may also lead to differences amongst individuals in protection from or progression
to tuberculosis. 
Methodology: We analysed the expression level of 45 genes from whole blood in a total of 
47 individuals (23 healthy household contacts and 24 microbiologically confirmed new 
smear positive pulmonary TB patients) in Addis Ababa using a dual colour multiplex ligation-
dependent probe amplification (MLPA) technique to assess gene expression profiles that 
may be used to distinguish TB cases and their contacts and also latently infected and 
uninfected household contacts 
Results: The gene expression level of BLR-1, Bcl-2, IL-4d2, IL-7R, FcgR1A, MARCO, MMP-9, 
CCL-19, and LTF have sufficient discriminatory power between sputum smear positive TB 
cases and household contacts with AUCs of 0.84, 0.81, 0.79, 0.79, 0.78, 0.76, 0.75, 0.75 and 
0.68 respectively. The combination of Bcl-2, BLR-1, FcgR1A, IL-4d2 and MARCO identified 
95.83% of active TB cases and 95.65% of household contacts without TB. The expression of 
CCL-19, TGFb1, and Foxp3 showed significant differences between latently infected and 
uninfected contacts with AUCs of 0.85, 0.82, and 0.75 respectively whereas the combination 
of BPI, CCL-19, FoxP3, FPR1 and TGFb1 identified 90.9% of QFT negative and 91.6% of QFT 
positive household contacts.
Conclusion: Expression of single and especially combinations of genes can accurately 
differentiate between active tuberculosis cases and non-tuberculosis cases as well as 
between latently infected and uninfected contacts.
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3.1 Introduction
An effective immune response controls infection with M. tuberculosis in a majority of 
infected individuals and it is only 10% of the infected who will develop clinical disease and 
symptoms within the first two years after infection (primary TB) and another 5% develop 
the disease later in life (reactivation TB). This raises the question ‘‘what is different about 
those who control tuberculosis infection and who fail to control tuberculosis infection?’’ 
Many studies have confirmed that genetic factors are involved in the disease and could be a 
key difference in the different outcomes of M. tuberculosis infection (Möller and Hoal; 
2010). A recent study showed a significant difference in the type and magnitude of immune 
responses against BCG between UK and Malawi children where Th1 related cytokines were 
present at higher levels in the UK infants whereas the innate proinflammatory cytokines, 
regulatory cytokines, interleukin 17, Th2 cytokines, chemokines, and growth factors were 
higher in the Malawi infants, which could be due to genetic but also environmental factors 
(Lalor et al.; 2011). 
Apart from gene polymorphism and mutation which leads to differences among individuals 
(Sakai et al.; 2001; Awomoyi et al.; 2002; Kim et al.; 2003; López-Maderuelo et al.; 2003; 
Cooke et al.; 2006; Ates et al.; 2008), there are also changes in levels of gene expression 
when cells migrate to and from sites of M. tuberculosis infection and interact with 
mycobacteria, which could also lead to differences in susceptibility (Jacobsen et al.; 2007; 
Mistry et al.; 2007; Lu C et al.; 2011; Maertzdorf et al.; 2011). Therefore, upregulated or 
downregulated genes may aid as biomarkers to distinguish the different clinical tuberculosis 
infection groups. Protective immunity against tuberculosis is associated with Th1 dominated 
cytokines; particularly IFN-g, however, different studies have indicated that the level of IFN-g
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alone does not constitute a correlate of protection although its presence is important 
(Dockrell; 2007; Lalvani and Millington; 2008). Therefore, additional biomarkers, which 
clearly indicate protection or susceptibility against TB are much needed. Recent studies 
have indicated that Fc gamma receptor 1B (FCgR1B) (Maertzdorf et al.; 2011), combined 
expression patterns of FCgR1A (CD64), RAB33A and LTF (lactoferrin) (Jacobsen et al.; 2007)
and CD3e, CD8a, IL7R, BLR1, CD19, FCGR1A, CXCL10, CD4, TNF, BCL2, MMP-9, Foxp3, CASP8, 
CCL-4, TNRFSF1A, CASP8, Bcl2 and TNF (Joosten et al.; 2012) show discriminating power 
between TB and LTBI. Expression of RIN3, LY6G6D, TEX264, and C14orf2 genes discriminate
active, cured, recurrent or latent TB (Mistry et al.; 2007). Therefore, we analysed the 
expression level of 45 genes targeting immune cell subset markers, T regulatory markers, 
effector T cell markers and apoptosis related genes and four housekeeping genes using a 
dual colour multiplex ligation-dependent probe amplification technique to assess gene 
expression profiles to distinguish the different clinical tuberculosis groups. These markers 
were chosen by the laboratory of Prof Tom Ottenhoff for a MLPA gene set, which was based 
on current literature and work in their laboratory.
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3.2 Materials and Methods
A total of 47 subjects (23 healthy household contacts and 24 microbiologically confirmed 
new smear positive pulmonary TB patients) attending Arada, T/Haimanot, Kirkos and W-23
health centres in Addis Ababa were recruited. The diagnosis of TB in the health centres was 
based on the national guidelines of at least two positive smears for acid-fast bacilli (AFB) in 
three specimens collected from each patient as spot-morning-spot samples. All sputum 
samples from TB cases were cultured following the protocol described in the methodology 
section (2.4.6). 
Quantiferon-Gold In Tube (QFT-GIT)
Latent TB infection was detected by performance of QFT-GIT as per the protocol described 
in the methodology section of the thesis (2.4.2).
Blood collection and RNA Extraction
Blood was collected with PAXgene tube and RNA extraction was performed following the 
manufacturer’s instructions (PAXgene Blood RNA Kit, PreAnalytiX, QIAGEN) as described in 
the methodology section of the thesis (2.4.4).
Multiplex Ligation-dependent Probe Amplification (MLPA)
MLPA was performed following the protocol described in the methodology section of the 
thesis (2.4.5).
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Target Genes
A probe set has been designed for the GC 6-74 TB biomarker project by the Leiden
University Medical Center (LUMC), Leiden, The Netherlands and this set of probes contains 
primers for forty five genes targeting immune cell subset markers, T regulatory cell markers, 
effector T cell markers, apoptosis related genes and four housekeeping genes. A list of these 
genes is shown in the methodology section (table 2.1).
Statistical analysis
The data were analyzed using Graph pad prism software, version 4.0 and STATISTICA 
software, version 10. The nonparametric Mann–Whitney U test was performed to assess
the significance of the observed differences. General discriminant analysis (GDA) and 
receiver operator characteristic (ROC) curve analysis were used to evaluate the predictive 
abilities of combinations of biomarkers and generate cut-off values for differentiating 
between M. tuberculosis infection states. A P value less than 0.05 was considered as 
statistically significant.
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3.3 Result
We enrolled 24 subjects with active tuberculosis (12 HIV positive and 12 HIV negative) and 
23 HIV negative household contacts comprising 12 QFT-GIT positive and 11 QFT-GIT 
negative household contacts. The mean age of TB patients was 31.6 + 1.4 and 46.5% of the 
participants were females. The mean age for household contacts was 28.3+2.3 and 47.6% of 
household contacts were females. All HIV positive TB patients were ART naïve with a mean 
CD4 count of 326 ±31.2 cells/•L. 
3.3.1 Gene expression of TB patients and household contacts
RNA samples from 24 TB patients and 23 healthy household contacts were analysed with 
MLPA and a significant gene expression difference was observed between these two groups. 
The gene expression levels of BLR-1, MARCO, CCL-19, MMP-9, LTF, Bcl-2, and FCgR1A were 
statistically higher in TB patients than contacts (p<0.05), whereas the expression level of IL-
4d2 and IL-7R were statistically higher in healthy contacts than TB cases (p<0.05) (Figure 3-
1).
*
**
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Figure 3-1 Gene expressions in household contacts and TB cases.
Box plots are shown where the horizontal lines indicate medians of household contacts 
(white bars) and TB cases (grey bars) and the lower and upper edge of each box indicate the 
25th and 75th percentiles, respectively. Data were analysed using the non-parametric
Mann-Whitney test with p-values indicating significant differences after transformation of
Log2 values.*P<0.05;**P<0.001
We did a multivariate analysis and a combination of five genes gave a better discriminatory 
power with the combination of Bcl2, BLR1, MARCO FcgR1A and IL-4d2 detecting 95.65% of 
household contacts in a resubstitution classification matrix and after leave-one out cross 
validation. 95.83% of TB cases were correctly classified in a resubstitution classification 
matrix and after leave-one out cross validation (Table 3-2).
Table 3-1  General discriminate analysis of five marker combinations to discriminate active 
tuberculosis and household contacts
Genes
Resubstitution 
clasification 
Matrix
Leave-one-out
cross 
validation
Resubstitution 
classification 
Matrix
Leave-one-out 
cross 
validation
Wilks 
lambda 
value f p Value
Bcl2, BLR1, FcgR1A, IFN g, IL4d2 95.65 91.3 95.83 95.83 0.74 14 <0.001
Bcl2, FcgR1A, IFN g, IL4d2, MARCO 91.3 91.3 95.83 91.66 0.72 15.8 <0.001
Bcl2, BLR1, CD163, FcgR1A, IL4d2 95.65 95.65 91.66 87.5 0.75 13.65 <0.001
Bcl2, BLR1,FcgR1A, IL4d2, MARCO 95.65 95.65 95.83 91.66 0.73 14.95 <0.001
Bcl2, CD19,FcgR1A, IL4d2, MARCO 95.65 95.65 91.66 91.66 0.75 13.21 <0.001
Bcl2, BLR1, CD19, FcgR1A, IL4d2 91.3 91.3 95.83 87.5 0.77 11.98 0.0013
Bcl2, BPI, FcgR1A, IL4d2, MARCO 95.65 95.65 91.66 95.83 0.72 16.11 <0.001
BLR 1, FcgR1A, IFN g, IL4d2, MMP9 95.65 86.95 95.83 91.66 0.75 13.46 <0.001
BLR 1, FcgR1A, IFN g, IL4d2, RAB13 91.3 86.95 95.83 91.66 0.76 13.13 <0.001
Bcl2, FcgR1A, IL4d2, MARCO, SPP1 95.65 95.65 95.83 87.5 0.71 16.7 <0.001
Household contacts TB cases
***
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A general discriminant analysis (GDA) of the data indicated that optimal discrimination of TB 
cases and non-TB contacts could be achieved with combinations of 5 variables. FcgR1A and 
IL4d2 were the most frequently occurring markers in the GDA biomarker combinations 
differentiating between the TB cases and household contacts (figure 3-2).
Figure 3-2 Frequency of individual analytes in top 10 models for discriminating between 
active TB cases and household contacts.
The columns represent the number of inclusions of individual markers into the most 
accurate five-analyte models by general discriminant analysis for discriminating between 
active pulmonary TB cases and contacts.
These most accurate single gene markers that differentiated TB cases and contacts were 
BLR1, Bcl2, IL-4d2, IL7R, FcgR1A, MARCO, MMP-9, CCL-19, and LTF with AUCs of 0.84, 0.81, 
0.79, 0.79, 0.78, 0.76, 0.75, 0.75 and 0.68 respectively (Figure 3-3). 
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Figure 3-3 Receiver operator characteristics curves showing the accuracies of individual 
analytes in discriminating between active TB cases and household contacts.
Receiver operator characteristic (ROC) curves for the accuracies of single analytes to 
differentiate between active TB and household contacts. AUC = Area under the curve.
3.3.2 Gene expression of latently infected household contacts
We further classified the household contacts into latently infected and non-infected groups 
using the QFT-GIT test to see the effect of latent tuberculosis on the expression level of 
different genes. The expression level of Foxp3, CCL-19 and TGFb were significantly higher
(p<0.05) in QFT positive than QFT negative contacts (figure 3-4). 
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Figure 3-4 Gene expression in Quantiferon positive and Quantiferon negative household 
contacts.
Box plots are shown with the horizontal lines indicating median levels of Quantiferon positive (white 
bars) and Quantiferon negative (grey bars) household contacts. The lower and upper edge of each 
box indicates the 25th and 75th percentiles, respectively. Data were analysed using the 
nonparametric Mann-Whitney test with p-values indicating significant differences after 
transformation of data to Log2 values.*P<0.05.
We did multivariate analysis and found that a combination of five genes gave a better 
discriminatory level with the best performing combination of BPI, CCL19, FoxP3, FPR1 and 
TGFb1 detecting 90.9 % QFT negative household contacts in a resubstitution classification 
matrix.  90.9% of QFT negative contacts were correctly classified after leave-one out cross 
validation, 91.6% in a resubstitution classification matrix and 91.6% after leave-one out 
cross validation (Table 3-2).
*
*
*
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Table 3-2 General discriminate analysis of five marker combinations to discriminate 
latently infected (QFT positive) and uninfected (Quantiferon negative) household 
contacts.
Genes
Resubstitution 
clasification 
Matrix
Leave-one-out
cross 
validation
Resubstitution 
classification 
Matrix
Leave-one-out 
cross 
validation
Wilks 
lambda 
value f p Value
BPI, CASP8, CCL19, FOXP3 and TGFb1 90.9 81.8 91.6 91.6 0.84 17.45 0.093
BPI, CCL19, FOXP3,TGFb1 and TIMP2 90.9 81.8 83.3 83.3 0.74 17.67 0.027
CASP8, CCL13,  CCL19, FOXP3 and TGFb1 81.8 81.8 91.6 91.6 0.86 2.74 0.116
CCL19, CD14, FOXP3, IL2RA and TIMP2 90.9 90.9 83.3 83.3 0.62 10.22 0.005
CASP8, CCL19, FOXP3, RAB24 and TIMP2 81.8 81.8 91.6 91.6 0.92 1.54 0.23
CASP8, CCL19, CD163, FOXP3 and TGFb1 90.9 81.8 91.6 91.6 0.92 1.53 0.23
CCL19, CD4, FOXP3, IL2RA and TIMP2 90.9 90.9 83.3 83.3 0.63 9.76 0.006
BPI, CCL19, FOXP3,FPR1 and TGFb1 90.9 90.9 91.6 91.6 0.6 11.08 0.004
CASP8, CCL19, FASL, FOXP3 and TGFb1 90.9 90.9 83.3 83.3 0.96 0.55 0.46
BPI, CCL19, FOXP3,SEC14L1 and TGFb1 81.8 81.8 91.6 83.3 0.74 5.85 0.03
QFT negative QFT positive 
A general discriminant analysis (GDA) of the data indicated that optimal discrimination of 
latently infected and uninfected household contacts could be achieved with combinations of 
five variables, BPI, CCL19, Foxp3, FPR1 and TGFb1. A combination of BPI, CCL19, FoxP3, FPR1 
and TGFb1 detects 90.9 % QFT negative household contacts in a resubstitution classification 
matrix and 90.9% after leave-one out cross validation and 91.6% detection of QFT negative 
in resubstitution classification matrix and 91.6% after leave-one out cross validation. FoxP3 
and CCL19 were the most frequently occurring markers in the GDA biomarker combinations 
differentiating between latently infected and uninfected household contacts (Figure 3-5).
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Figure 3-5 Frequency of individual analytes in top 10 models for discriminating between 
latently infected and uninfected household contacts.
The columns represent the number of inclusions of individual markers into the most 
accurate five-analyte models by general discriminant for discriminating between QFT 
positive and QFT negative contacts
The most accurate single gene markers that differentiated QFT positive and negative 
contacts were CCL-19, TGFb1 and Foxp3 with AUCs of 0.85, 0.82, and 0.75 respectively 
(Figure 3-6). 
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Figure 3-6 Receiver operator characteristics curves showing the accuracies of individual 
analytes in discriminating between latently infected and uninfected household contacts. 
Receiver operator characteristic (ROC) curves for the accuracies of single analytes to differentiate 
between latently infected and uninfected household contacts. AUC = Area under the curve.
3.3.3 Effect of HIV co-infection on gene expression of TB patients
We have also analysed the effect of HIV co-infection on the expression level of different 
genes in TB patients. We compared 12 patients in each group and we found that the
expression levels of CD8a, LAG-3, IL-10, CCL-4 and CCL-22 were different in HIV positive and 
HIV negative TB patients. The level of CD8a, LAG-3, and IL-10 was significantly higher 
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(p<0.05) in HIV positive TB cases than HIV negative TB cases whereas the level of CCL-4 and 
CCL-22 was significantly higher (p<0.05) in HIV negative TB cases than HIV positive TB cases
(figure 3-7).
Figure 3-7 Gene expression in HIV positive and HIV negative TB cases.
Box plots are shown with the horizontal line indicating median expression of HIV positive (white 
bars) and HIV negative (grey bars) TB cases. Lower and upper edge of each box indicates the 25th 
and 75th percentiles, respectively. Data were analysed using the nonparametric Mann-Whitney test 
with p-values indicating significant differences after transformation of data to Log2 values.* P<0.05.
* *
*
* *
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3.4 Discussion
Quantitative changes in gene expression levels can potentially be used as biomarkers to 
classify the different clinical groups of M. tuberculosis infection, as well as the effects of 
drugs and vaccines. We need a broader approach aimed at characterizing unique gene 
expression profiles due to the complexity of the infection process and outcomes of M. 
tuberculosis infection. A biomarker or combination of biomarkers that could be used to 
distinguish different clinical tuberculosis groups would be greatly beneficial.
In this study we used a dual colour reverse transcriptase MLPA technique to simultaneously 
identify multiple genes that are differentially expressed in tuberculosis cases and their 
contacts. We tested 45 genes and identified nine genes, which were differentially expressed 
between tuberculosis cases and their contacts. 
The expression of FcgR1A, LTF, BLR-1, MARCO, CCL-19, MMP-9, CCL-4, and Bcl-2 in whole 
blood was statistically higher in TB patients than contacts, whereas the expression levels of 
IL-4d2 and IL-7R were statistically higher in healthy contacts. Similar to our finding the 
higher expression of FcgR1A and LTF in TB patients has been reported from previous studies 
in Germany (Jacobsen et al.; 2007) with microarray analysis of PBMCs from TB patients and 
healthy donors and in Gambia and Paraguay with MLPA (Joosten S et al.; 2012). FcgR1A and 
LTF are essential components of antimicrobial defense and blocking of induction of FcgR1A
is one major target for the survival strategy of M. tuberculosis (Ting et al.; 1999). Lactoferrin 
modulates both the innate and adaptive immune response and there are reports showing 
the potential of lactoferrin as an adjuvant for BCG vaccination (Hwang et al.; 2011). Another 
study in a murine model also showed that susceptibility to TB could be reduced by avoiding 
overload of iron using LTF (Schaible et al.; 2002). 
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BLR-1 (CXCR5) is a chemokine receptor of a potent B cell attractor, CXCL-13, and the higher 
level of this gene in TB patients might help in sustaining the expression of its ligand CXCL-13 
which in turn attracts B cells. The role of B cells in immune response against TB has been 
documented in various studies (Abebe and Bjune; 2009; Zhang et al.; 2011). The higher level 
of CCL-19 in TB patients could be due to the presence of active infection where a number of 
important cells including macrophages and T cells are recruited for containing infection. 
Different in vivo and in vitro studies indicated that M. tuberculosis infection of human 
monocyte derived macrophages, alveolar macrophages, and CD4 T cells induced 
upregulation of chemokine receptors and their ligands (Kurashima et al.; 1997; Lin et al.; 
1998; Algood et al.; 2003; Pokkali and Das; 2009).
The higher level of MMP-9 and MARCO in TB infections is in line with other previous 
reports, which reported a higher level of MMP-9 in TB cases where it facilitates early 
dissemination of the bacteria with subsequent recruitment of macrophages, induction of 
Th1 type immunity and granuloma formation (Izzo et al.; 2004; Taylor et al.; 2006). MARCO
is a phagocytic receptor and M. tuberculosis uses different receptors to infect macrophages. 
Previous work in mouse models also showed upregulation of MARCO genes after BCG 
infection (Ito et al.; 1999) and a low proinflammatory response of MARCO-/- mice in 
response to infection with virulent M. tuberculosis (Bowdish et al.; 2009).
The other genes, which had a discriminatory expression, were Bcl-2 and IL-4d2. Bcl-2 is an
anti-apoptotic gene and in this study its expression was higher in TB patients. Apoptosis is 
believed to be one mechanism of immune responses by the host for eliminating infected 
cells without releasing viable bacteria and previous studies in Ethiopia and Gambia (Abebe 
et al.; 2010; Joosten S et al.; 2012) indicated upregulation of apoptotic genes in TB patients 
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although we could not repeat their finding in this study. However, the higher expression of 
Bcl-2 in this study could be a survival strategy of the pathogen as previous studies also show 
that M. tuberculosis or its derived products inhibited apoptosis (Abebe et al.; 2011). 
Expression of IL-4d2 is higher in contacts and it is a recently described splice variant of IL-4,
which inhibits IL-4 activity. Different studies showed that latently infected individuals 
express high levels of Th1 cytokines and the IL-4 antagonist IL-4d2 and individuals with a 
high IL-4d2/IL-4 ratio controlled M. tuberculosis infection (Wassie et al.; 2008).
The expression of CCL-19, TGFb1, and Foxp3 significantly discriminates latently infected and 
uninfected contacts. The expression of all genes was higher in latently infected individuals 
and their higher expression might be due to a recent M. tuberculosis infection, which could 
lead to immune activation and recruitment of immune cells. CCL-19 is an important 
molecule for recruiting activated immune cells and increased expression of regulatory 
molecules could be important to avoid prolonged immune activation and immunopathology 
as regulatory molecules like Foxp3, and TGFb1 regulate immune response during infection 
to prevent excessive inflammation and tissue damage (Ribeiro-Rodrigues et al.; 2006). 
Another study also showed activation and expansion of both T effector cells and Foxp3 (+) 
Treg populations early in M. tuberculosis infection. IL-2 induces expression of both effector 
Tcells and Foxp3 and confers resistance against severe M. tuberculosis infection (Chen et al.; 
2012).
The other groups, which showed a discriminatory gene expression profile, were HIV positive 
and HIV negative TB patients. The expression of CD8a, LAG-3, IL-10, CCL-4 and CCL-22
significantly discriminates the two groups where CD8a, LAG-3 and IL-10 genes were higher 
in HIV positive TB cases than in HIV negative TB cases whereas the expression level of CCL-4 
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and CCL-22 was higher in HIV negative TB patients. The reduced level of CCL-4 and CCL-22 in 
HIV positive TB cases could be due to the significant loss of CD4 cells due to HIV. In one in 
vitro study it was shown that activated CD4 cells produce HIV 1 suppressive factors, like CCL-
22 and CCL-4. These act on CCR-4 and CXCR-5 receptors (Abdelwahab et al.; 2003). The 
higher level of IL-10 in co-infected TB patients might be due to the immune exhaustion 
induced by HIV where the HIV-specific CD4 T cell response is inhibited through upregulation 
of IL-10. Previous studies suggested that the level of IL-10 is elevated in chronic HIV disease 
(Kwon D et al.; 2012). The higher level of CD8a in HIV positive TB patients could be due to 
the role of CD8 cells in limiting disease progression during chronic infection as there are 
studies which showed very rapid HIV/AIDS progression in the absence of HIV-1-specific CD8+ 
T cells (Feng et al.; 2010).
In conclusion, active tuberculosis cases versus non tuberculosis cases or latently infected 
versus uninfected contacts could be accurately differentiated using expression of single 
genes with combinations of genes providing improved discriminatory power in 
differentiating between different clinical groups of tuberculosis infection. However, there is 
a need to validate gene biosignatures in larger studies and in other cohorts prospectively.
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CHAPTER 4
4. Plasma cytokines and chemokines differentiate between active and 
non-active tuberculosis infection
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Abstract
Background: Identifying biomarkers that could differentiate between the different clinical 
conditions of M. tuberculosis infection and treatment outcomes have paramount 
importance in TB control. 
Method: We analysed ex vivo plasma samples from 33 TB patients (17 HIV negative and 16 
HIV positive) and 30 healthy household contacts with Luminex. 
Result: We found statistically significant differences (p<0.05) in median plasma levels of 
EGF, fractalkine, IFN-g, IL-4, MCP-3 and IP-10 between contacts and TB patients. However, 
none of the cytokines were significantly different in latently infected and uninfected 
contacts (P>0.05). HIV does not affect the median plasma level of any of the cytokines or 
chemokines and there was not significant difference between HIV positive and HIV negative 
TB patients (P>0.05) in any of the cytokines or chemokines. The median plasma levels of 
IFN-g, IL-4, MCP-3, MIP-1b and IP-10 were significantly different (P<0.05) before treatment 
and after treatment. 
Conclusion: Plasma cytokines and chemokines could be used as immunological markers for 
diagnosing active TB disease and for monitoring effective anti tuberculosis therapy.
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4.1 Introduction
A more simple and accurate diagnosis of active TB disease and latent tuberculosis and 
monitoring of anti-TB treatment are crucial for curbing the current TB epidemic. The more 
than a century old smear microscopy test is the most widely used technique for TB diagnosis 
and for monitoring efficacy of anti TB therapy. Similarly, until recently the old tuberculin
skin test (TST) has been used solely as a diagnostic test for latent tuberculosis infection. 
However, in recent times two new in vitro T cell based immuno assays were developed,
which measure IFN gamma (IFN-g) response against M. tuberculosis specific antigens, early 
secreted antigenic target 6 (ESAT-6) and culture filtrate protein 10 (CFP-10). The two T-cell-
based Interferon Gamma Release Assays (IGRAs) are commercially available and widely used 
for diagnostic and research purposes: QuantiFERON TB-GOLD In-Tube (QFT-G-IT) (Cellestis 
Ltd., Carnegie, Australia) which includes an additional M. tuberculosis-specific antigen TB7.7
and T-SPOT.TB (Oxford Immunotec, Abingdon, UK). These tests are reported to be less 
affected by Bacillus Calmette Guerin (BCG) vaccination than the TST and different studies 
indicated that IGRAs are more sensitive and specific than TST (Diel et al.; 2010). However 
both tests do not differentiate active TB from latent TB infection.
There are different studies using different approaches and samples reporting different 
cytokines and or chemokines with a potential of discriminating the different clinical 
outcomes of M. tuberculosis infection and anti TB treatment. Stimulation of PBMC with M. 
tuberculosis antigens gives rise to high levels of Th1 cytokines and the IL-4 antagonist IL-4d2 
in protected individuals in comparison with non protected individuals (Demissie et al.; 2004)
and proinflamatory cytokines such as TNF, IL-12(p40) and IL-17 are increased in TB cases 
and can discriminate between active TB disease and latent infection (Sutherland et al.; 
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2010). Serum or plasma of TB cases have high levels of IL-8, IP-10, MCP-1, and MIP-1 b in 
comparison with non TB cases (Juffermans et al.; 1999; Azzurri et al.; 2005; Siawaya et al.; 
2009a) and mRNA level of individuals with a high IL-4d2/IL-4 ratio controlled M. tuberculosis
infection (Wassie et al.; 2008). Another study also showed that levels of single or 
combinations of three host markers (selected from EGF, sCD40L, MIP-1•, VEGF, TGF-• or IL-
1•) in stimulated or unstimulated plasma samples from QFT supernatants had promising 
discriminating ability between latent and active TB (Chegou et al.; 2009). The increase of 
some chemokines in supernatants from whole blood stimulated with Mycobacterium 
tuberculosis-specific antigens was reported to be a marker of tuberculosis infection 
(Ruhwald et al., 2011).  
On the basis of this line of research, in the current study we addressed the possibility of 
using cytokines and chemokines from unstimulated plasma samples for detection of active 
TB disease, latent TB, discriminating active TB cases from latently infected contacts and for 
monitoring anti TB treatment outcome.
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4.2 Materials and methods
Study subjects
In this prospective study, 33 subjects with active TB disease (17 HIV negative and 16 HIV 
positive) and 30 healthy household contacts (15 QFT-GIT positive and 15 QFT-GIT negative) 
were recruited from selected health centers in Addis Ababa, Ethiopia. The diagnosis of TB in 
the health centres was based on the national guidelines of at least two positive smears for 
acid-fast bacilli (AFB) in three specimens collected from each patient as spot-morning-spot.
All sputum samples from TB cases were cultured for mycobacteria following the protocol 
described in the methodology section (2.4.6). 
Household contacts were recruited through the active TB cases following the definition in 
the methodology section. The presence of HIV infection was ruled out using rapid tests (Stat 
pack, KHP and Unigold as a tie breaker) as per the national guideline. QFT-G-IT test was used 
to detect latent tuberculosis and we measured plasma cytokines using Luminex as described 
in the methodology part of the thesis.
Statistical analysis
The data were analyzed using Graph pad prism software, version 4.0. Nonparametric Mann–
Whitney U tests were performed for comparison between groups A multivariate analysis 
was done using STATISTICA Version 10. A P value less than 0.05 was considered as 
statistically significant.
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4.3 Result
4.3.1 Demographic characteristics
We enrolled 33 subjects with active tuberculosis and 30 household contacts. Among the TB 
cases, 16 were HIV positive and all were ART naïve with a mean CD4 count of 310 ±23.9
cells/•L. The household contacts comprising 15 QFT-GIT positive and 15 QFT-GIT negative 
contacts were all HIV negative. The mean age of TB patients was 32.4 + 1.7 and 48.5% of the 
participants were females. The mean age of household contacts was 29.7+2.7 and 47.4% of 
household contacts were female. 
4.3.2 Cytokines and /or chemokines diagnostic potential of TB cases
Plasma samples from 33 TB patients (17 HIV negative and 16 HIV positive) and 30 healthy 
household contacts were analysed with Luminex without any stimulation and we found that 
significantly different levels of cytokines and/or chemokines between the different groups. 
The median level of EGF, FRACTALKINE, IFN-g, IL-4, MCP-3 and IP-10 were statistically 
significant different (p<0.05) between TB patients and their contacts (Figure 4-1).
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Figure 4-1  Plasma cytokine and chemokine levels in TB cases and their household 
contacts.
Unstimulated plasma samples from TB cases (n = 33) and household contacts (n = 30) were assessed 
by multiplex cytokine analysis. A) Anti-inflammatory cytokines (IL-10 and IL-4), B) Growth factors 
(EGF and VEGF), C) Pro-inflammatory cytokines (IFN-g, IL 12(p40), and TNF) and D) Chemokines (IP-
10, MCP-1, MCP-3, MIP-1b and fractalkine). The horizontal line indicates median values of TB cases 
(filled circles) and household contacts (open circles). Data were analysed using nonparametric Mann-
Whitney test with p-values indicating significant differences after transformation of data to Log10 
values.*p<0.05, **p<0.001.
C
D
*
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The list below shows median levels and ranges of all markers that were statistically 
significantly different between cases and contacts. The levels of markers in contacts were: 
EGF (0.5pg/ml, range 0.5-2.1pg/ml), fractalkine (0.5pg/ml, range 0.5-2.7pg/ml), IFN-g 
(1.03pg/ml, range 1.03-2.2pg/ml), IL-4 (0.5pg/ml, range 0.5-1.7pg/ml), MCP-3 (1.16pg/ml, 
range 0.5-2.3pg/ml) and IP-10 (2.34pg/ml, range 1.9-2.98pg/ml). Median levels and ranges 
in TB patients were: EGF (1.79pg/ml, range 0.5-2.7pg/ml), fractalkine (1.79pg/ml, range 0.5-
2.5pg/ml), IFN-g (0.84pg/ml, range 0.5-2.09pg/ml), IL-4 (1.04pg/ml, range 0.5-1.39pg/ml), 
MCP-3 (1.68pg/ml, range 1.03-2.2pg/ml), IP-10 (3.57pg/ml, range 2.2-4.2pg/ml).
We did multivariate analysis and found that a combination of five cytokines gave a better 
discriminatory level with the best model including a combination of fractalkine, IFN-g, IL-4, 
IP-10 and TNF with 96.87 % detection of TB cases in a resubstitution classification matrix 
and with 96.7% after leave-one out cross validation and 100% detection of household 
contacts (Table 4-1).
Table 4-1 General discriminate analysis of five marker combinations to discriminate active 
tuberculosis and household contacts
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Cytokines
Resubstitution 
clasification 
Matrix
Leave-one-out
cross 
validation
Resubstitution 
classification 
Matrix
Leave-one-out 
cross 
validation
Wilks 
lambda 
value f p Value
fractalikine, IFN g, IL 4, IP 10 and TNF 96.87 96.87 100 100 0.69 25 <0.0001
fractalkine, IFN g,  IP 10, MCP 3 and MCP 1 96.87 93.75 100 93.3 0.81 13 0.0006
fractalkine, IFN g, IL 4, IP 10 and MIP 1 96.87 93.75 100 100 0.69 24 <0.0001
IFN G, IL 12, IP 10, MCP 3, and MIP 1 96.87 93.75 96.66 93.33 0.85 9.4 0.003
IFN G, IL 12, IP 10, MCP 3, and TNF 96.87 96.87 96.66 93.33 0.77 16 <0.0001
fractalkine, IFN g, IL 12, IL4 and IP 10 96.87 96.87 100 100 0.54 48 <0.0001
EGF, fractalkine, IFN g, IL 4 and  IP 10 96.87 93.75 100 100 0.51 53 <0.0001
fractalkine, IFN g, IP 10, MCP 3, and TNF 96.96 93.93 96.66 93.33 0.7 24 <0.0001
fractalkine, IFN g, IL 12, IP 10, and MCP 3 96.87 96.87 96.66 93.33 0.57 42 <0.001
fractalkine, IFN g, IL 4, IP 10 and VEGF 96.87 96.87 100 100 0.51 53 <0.001
IFN G, IP 10, MCP 3, MIP 1 and TNF 96.87 96.87 96.66 93.33 0.9 5.9 0.018
fractalkine, IFN g, IL 4, IP 10 and MCP 1 96.87 96.87 100 96.66 0.74 20 <0.0001
fractalkine, IFN g, IL 12,  IP 10 and TNF 96.87 93.75 100 96.66 0.7 23 <0.0001
EGF, fractalkine, IFN g, IL 4, IP 10 and TNF 93.75 93.75 100 100 0.69 25 <0.0001
IFN g, IL 4, IP 10, MCP 3 and TNF 96.87 96.87 96.66 93.33 0.75 19 <0.0001
fractalkine, IFN g, IP 10, MCP 1, and TNF 96.96 93.93 100 96.66 0.8 14 0.0004
fractalkine, IFN g, IP 10, MIP 1, and TNF 93.75 93.75 100 96.66 0.77 17 0.00014
fractalkine, IFN g, IL 10, IL4 and IP 10 96.87 96.87 100 100 0.54 47 <0.0001
fractalkine, IFN g, IL 4, IP 10 and MCP 3 96.87 93.75 100 93.33 0.52 51 <0.0001
EGF, IFN g, IP10, MCP 3, MIP 1 93.75 93.75 93.33 93.33 0.84 11 0.0019
TB cases Non TB cases
A general discriminant analysis (GDA) of the data indicated that optimal prediction of TB 
cases could be achieved with combinations of 5 variables. IP-10 and IFN-g were the most 
frequently occurring markers in the GDA biomarker combinations differentiating between 
the TB cases and household contacts (figure 4-2). 
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Figure 4-2 Frequency of individual analytes in top 20 models for discriminating between 
active TB cases and household contacts.
The columns represent the number of inclusions of individual markers into the most accurate five-
analyte models by general discriminant for discriminating between active pulmonary TB cases 
contacts.
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4.3.3 Diagnostic potential of cytokines and /or chemokines in latent TB cases
Moreover, we further classified the household contacts into latently infected and non-
infected groups by using Quantiferon-Gold in tube test. Similarly, the plasma level EGF, 
FRACTALKINE, IFN-g, IL-4, MCP-3 and IP-10 were statistically higher in TB patients than QFT 
positive or QFT negative subjects (p<0.05), however, none of the cytokines were able to 
differentiate QFT positive from QFT negative groups (p>0.05) (figure 4-3). 
Figure 4-3 Plasma cytokine and chemokine levels in QFT negative and QFT positive 
household contacts.
Unstimulated plasma samples from QFT negative (n = 15) and QFT positive (n = 15) were assessed by 
multiplex cytokine analysis. A) Anti-inflammatory cytokines (IL-10 and IL-4), B) Growth factors (EGF 
and VEGF), C) Pro-inflammatory cytokines (IFN-g, IL 12(p40), and TNF) and D) Chemokines (IP-10, 
MCP-1, MCP-3, MIP-1b and fractalkine). Horizontal line indicates median of QFT negative (filled 
circles) and QFT positive (open circles). Data were analysed using nonparametric Mann-Whitney test 
with p-values indicating significant differences after transformation of data to Log10 values.
A B
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4.3.4 Diagnostic potential of cytokines and /or chemokines in HIV positive 
and HIV negative TB cases
We found that the median plasma level of any of the cytokines/chemokines was not 
affected by HIV infection status although the HIV positive TB patients have a slightly higher
level of most of the cytokines and chemokines (Fig 4-4). 
Figure 4-4  Plasma cytokine and chemokine level in HIV negative and HIV positive TB 
cases.
Unstimulated plasma samples from HIV positive TB cases (n = 16) and HIV negative TB cases (n = 17) 
were assessed by multiplex cytokine analysis. A) Anti-inflammatory cytokines (IL-10 and IL-4), B) 
Growth factors (EGF and VEGF) C), Pro-inflammatory cytokines (IFN-g, IL 12(p40), and TNF) and D) 
Chemokines (IP-10, MCP-1, MCP-3, MIP-1b and fractalkine). Horizontal lines indicate median of HIV 
negative (filled circles) and HIV positive TB cases (open circles). Data were analysed using 
nonparametric Mann-Whitney test with p-values indicating significant differences after 
transformation of data to Log10 values.
A B
C D
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4.3.5 Cytokines and /or chemokines levels in TB cases before and after 
treatment
We also measured the plasma level of the cytokines and chemokines after 8 month of 
effective anti-TB therapy to see if any of these cytokines and/or chemokines showed a
treatment effect and we found that the median level of IFN-g, IL-4, IP-10, MCP-3 and MIP-
1b were statistically different (p<0.05) before treatment and after treatment (figure 4-5). All 
the cytokines that differentiated between TB cases and controls at baseline either increased 
or decreased to the level of household contacts after treatment, except MIP 1b were its 
level was not decreased to the level of household contacts.
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Figure 4-5 Plasma cytokine and chemokine levels in TB cases before treatment, after 
treatment and in household contacts.
Unstimulated plasma samples from TB cases before treatment (n = 15), TB cases after 
treatment (n=15) and household contacts (n = 30) was assessed by multiplex cytokine 
analysis. A) Anti-inflammatory cytokines (IL-10 and IL-4), B) Growth factors (EGF and VEGF), 
C) Pro-inflammatory cytokines (IFN-g, IL 12(p40), and TNF) and D) Chemokines (IP-10, MCP-
1, MCP-3, MIP-1b and fractalkine). Horizontal line indicates median of TB cases before 
treatment (filled circles), TB cases after treatment (open circles) and household contacts 
(filled triangle). Data were analysed using nonparametric Mann-Whitney test with p-values 
indicating significant differences after transformation of data to Log10 values. *p<0.05, 
**p<0.001.
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4.4 Discussion
In this study we determined the levels of different cytokines and chemokines directly from 
plasma in an endemic population as part of an effort to identify a single marker or 
combination of cytokines and/or chemokines which have a potential to detect active TB, 
differences between pre- and post-TB treatment time points and to discriminate between
infected and uninfected individuals. The main findings of this study are: (a) TB patients had 
significantly higher plasma concentrations of EGF, fractalkine, IL-4, MCP-3 and IP-10 and 
lower plasma concentration of IFN-g compared to household contacts irrespective of QFT 
status and; (b) None of the cytokines or chemokines measured were able to discriminate 
QFT positive (latently infected) contacts and QFT negative (non infected) contacts; and (c) 
The plasma level of IFN-g, IL-4, IP-10, MCP-3 and MIP-1b significantly changed after 
completion of anti-TB treatment.
In the present study we found that the median plasma level of IFN-g, IL-4, EGF, fractalkine, 
IP-10 and MCP-3 statistically discriminates (p<0.005) patients with active TB and healthy
household contacts suggesting that with assay optimization these cytokines and chemokines
alone or in combination might serve as markers which can help in diagnosing active TB 
disease directly from plasma without any additional laboratory manipulation. IFN-g
producing Th1 cells are essential to control mycobacterial replication through activation of 
macrophages and the prototype Th2 cytokine, IL-4, on the other hand downregulates 
activation of macrophages. In TB patients the Th1/Th2 bias shifts toward a more marked 
Th2 response and a lower IFN g/IL-4 points towards increase disease severity in TB patients 
(Demissie et al.; 2004). IL-4d2 is a recently described splice variant of IL-4, which inhibits IL-4 
activity and different studies showed that latently infected individuals express high levels of 
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Th1 cytokines and the IL-4 antagonist IL-4d2 and individuals with a high IL-4d2/IL-4 
controlled M. tuberculosis infection (Wassie et al.; 2008). EGF is an angiogenic factor and is 
involved in tissue repair and the higher level of this angiogenic protein in the plasma of TB 
patients might reflect the disease activity. The higher plasma level of EGF, VEGF and IP-10 is 
supported by other reports (Juffermans et al.; 1999; Azzurri et al.; 2005; Siawaya et al.; 
2009b) who have shown high levels of IP-10, EGF and VEGF in serum or plasma or pleural 
effusion of TB patients compared with contacts and controls although a recent paper was 
unable to reproduce the findings (Alessandri et al.; 2006) and showed that pulmonary TB 
patients and controls had no difference in the plasma concentration of MCP- 1 and IP-10.
Studies have also shown that M. tuberculosis specific stimulation induced IP-10 (CXCL-10) 
and the sensitivity of detecting M. tuberculosis infection appeared to be better than the 
Quantiferon test (Ruhwald et al.; 2008; Kabeera et al.; 2010; Belard et al.; 2011) and TB 
patients have high level of MCP-1, MCP-3, IL-1Ra, and IP-10 responses to TB antigen 
compared with controls (Ruhwald M et al.; 2009). However, another study did not
reproduce this finding and showed that active TB cases produce a higher level of IFN-g but 
not IP-10, MCP-2 and IL-2 after stimulation with RD1 selected peptides (Goletti et al.). The 
IP-10 and MCP-2 response after stimulation with RD1 in TB cases and their contacts was not 
significantly different but both groups induce higher IP-10 and MCP-2 compared to 
community controls; on the other hand all the three groups induce similar IL-2 response 
(Goletti et al.). Another study had also shown that detection of combinations of three host 
markers or single markers (selected from EGF, sCD40L, MIP-1•, VEGF, TGF-• or IL-1•) in 
stimulated or unstimulated plasma samples had promising discriminating ability between 
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latent and active TB. The highest single marker based test sensitivities and specificities were 
observed for EGFNil (90 and 84%) and for EGFAg-Nil (92 and 82%) (Chegou et al.; 2009).
When we grouped the household contacts into latently infected and uninfected based on 
the QFT-GIT test, the plasma level of EGF, fractalkine, IFN-g, IL-4, MCP-3 and IP-10 were 
statistically higher in TB patients than QFT positive or QFT negative subjects, however, none 
of the cytokines were able to differentiate QFT positive and QFT negative groups. In 
contrary to this, a recent study conducted in children showed a significantly higher plasma 
level but not MTB antigen stimulated level of IP-10 in latently infected children than TB 
patients and community controls (Whittaker et al.; 2008). On the other hand, a recent meta 
analysis claimed that IP-10 is less affected by infections other than TB and it could be used as 
a novel diagnostic marker for infection with M. tuberculosis (Belard et al.; 2011). However, 
the problem in this recent meta analysis is they only compared TB patients, healthy controls 
and non TB patients and they did not compare the IP-10 level in the latently infected and 
non infected groups.
We also assessed the effect of HIV on plasma levels of the different cytokines and 
chemokines of TB cases and we found that the median plasma level of any of the 
cytokines/chemokines was not affected and there was not statistically different between 
the two groups in any of the cytokines and chemokines. In our study the plasma level of 
EGF, fractalkine, IFN-g, IL-4, MCP-3 and IP-10 were equally high in both groups and can 
discriminate the TB patients from healthy household contacts irrespective of TB patients’
HIV serological status. The detection rate of the old smear microscopy or the newly 
developed IGRAs is very low in patients with severe TB and immunocompromised patients, 
which urges the need for exploring new biomarkers for the diagnosis of M.tuberculosis
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infection or TB disease particularly in most endemic countries where 50% of TB patients are 
HIV coinfected. 
The median plasma level of IFN-g, IL-4, MCP-3, MIP-1b and IP-10 changed after treatment. 
The median plasma level of IL-4 and IP-10 was significantly decreased whereas the level of 
IFN-g, MCP-3 and MIP-1b significantly increased after treatment. We know that IFN-g is a 
proinflammatory and IL-4 is an anti-inflammatory cytokine and it is reasonable to suggest 
the increased concentration of IFN-g and the reduced concentration of IL-4 might be due to 
the clearance of the actively multiplying bacteria and resolution of the disease by the 
antituberculosis treatment. Another study also indicated a similar finding where the plasma 
level of IP-10 decreased and MCP-1 and MIP-1b increased after successful treatment 
(Azzurri et al.; 2005; Siawaya et al.; 2009a). MCP-1 and MIP-1b are important chemokines 
and the increased concentration of these chemokines might help in the control of infection 
by attracting cells to the granuloma. Therefore, the utility of the aforementioned cytokines 
as indicators of antituberculosis treatment response should now be evaluated in large 
studies and in different settings and should include the evaluation of patients with
treatment failure.
In conclusion, the present study demonstrated that unstimulated plasma EGF, fractalkine, 
IFN-g, IL-4, MCP-3 and IP-10 level may have potential in new tools to diagnose both HIV 
positive and negative TB diseased subjects although none of these markers were able to 
differentiate latently infected and non-infected individuals. Moreover, we found that the 
plasma level of IFN-g, IL-4, MCP-3, MIP-1b and IP-10 changed significantly during anti TB 
therapy. Further studies are needed to define cut off points for a positive test result, and to 
explore the potential of these cytokines and chemokines in addition or as alternative to the 
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existing tests for the development of a rapid, sensitive and user friendly test for the 
diagnosis of active TB disease in all group of subjects and for monitoring effective anti 
tuberculosis therapy.
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CHAPTER 5
5. Diversity of Mycobacterium tuberculosis isolates from HIV positive 
and HIV negative new pulmonary tuberculosis cases in Addis Ababa, 
Ethiopia
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Abstract
Objectives: Understanding the genetic diversity of Mycobacterium tuberculosis is needed 
for a better understanding of epidemiology of TB and could have implications for 
development of new diagnostics, drugs, and vaccines. The aim of our study was to 
understand the genotypes of M. tuberculosis circulating in Addis Ababa.
Method: M. tuberculosis isolates were characterized using spoligotyping and were 
compared with the SpoIDB4 database of the Pasteur Institute of Guadeloupe. 
Result: A total of 53 different patterns were identified among 192 isolates examined. One 
hundred and sixty nine of the isolates were classified into one of the 33 shared SITs, 
whereas the remaining 23 corresponded to 20 orphan patterns. Fifty four percent of the 
isolates were ascribed to the T family, a family that has not been well defined to date. Other 
prominent families were CAS, Haarlem, LAM, Beijing, and Unknown comprising 26%, 12.5%, 
2.6%, 0.5%, and 2.1% respectively. Among HIV positive patients, 10 patterns were observed 
among 25 isolates, with the remaining one exhibiting a unique pattern. The T (38.5%), H 
(26.9%), and CAS (23.1%) families were the most common among HIV positive individuals. 
There was no significant difference in the distribution of strains in HIV positive and HIV 
negative TB patients except the H family.
Conclusion: The diversity of the M. tuberculosis strains found in this study was very high and 
there was no difference in the distribution of families in HIV positive and HIV negative TB 
patients. Tuberculosis transmission in Addis Ababa is due to only the modern M. 
tuberculosis families (CAS, LAM, T, Beijing, Haarlem, and U) despite the historical African 
origin of M. tuberculosis.
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5.1 Introduction
Tuberculosis (TB) continues to be a major public health problem in Ethiopia. Currently 
Ethiopia is rated 7th among the 22 high TB-burdened nations of the world, with a prevalence 
of 394 per 100,000 population in the year 2010 (WHO; 2011). This situation has been 
worsened by the country’s HIV/AIDS epidemic; HIV prevalence was 3.5% in 2009 and among 
TB patients, 15% were co-infected with HIV (1), and TB is the leading cause of mortality 
among HIV positive patients (FMoH.; 2009). Despite the historical origin of TB in the region 
and the high TB burden in the country, very limited information is available on the genetic 
diversity of M. tuberculosis strains and the impact of HIV disease on this diversity in the 
country.
Molecular typing techniques have been extensively used to speciate strains of M. 
tuberculosis involved in TB infections, providing insights into dissemination dynamics, 
evolutionary genetics, and detection of suspected outbreaks and person to person 
transmission (Brosch et al.; 2002a). Although recent studies are recommending the use of 
robust markers such as single nucleotide polymorphisms (SNP) or large sequence 
polymorphisms (LSP) for a better understanding of strain lineages (Comas and Gagneux; 
2011), Insertion sequence (IS) 6110 restriction fragment length polymorphism (IS6110 RFLP) 
has in the past served as a gold standard typing method (van Embden et al.; 1993; Kremer et 
al.; 1999). However, it is costly, time consuming, and not easily standardized across 
laboratories.
An alternative technique is a PCR amplification based technique, spacer oligonucleotide 
typing (spoligotyping), which analyses polymorphisms of direct repeat (DR) regions. The 
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technique is relatively simple, quick, and reliable. The method has been extensively used for 
simultaneous detection and typing of M. tuberculosis (Kamerbeek et al.; 1997a). Currently 
spoligotyping has been successfully applied to understand the emerging problem of 
multidrug-resistant (MDR) and extensively drug resistant (XDR) TB and to investigate the 
virulence of different strains of M. tuberculosis, as well as to better understand the 
epidemiology of TB (Affolabi et al.; 2009; Dong et al.; 2010; Rosales et al.; 2010; Viegas et 
al.; 2010; Afanas’ev et al.; 2011; Groenheit et al.; 2011). A recent study on molecular 
analysis of M. tuberculosis in Ethiopia described the diversity of strains although it failed to 
address the pattern in TB-HIV co-infection (Agonafir et al.; 2010). The present study aimed 
to provide additional insight into the diversity of clinical isolates in HIV positive and HIV 
negative patients in Addis Ababa, Ethiopia using spoligotyping and to compare the patterns 
obtained with those available in the international spoligotyping database, SpolDB4.0 of the 
Pasteur Institute of Guadeloupe.
5.2 Materials and Methods
M. tuberculosis strains and DNA isolation
A total of 192 M. tuberculosis isolates were collected between July 2009 and June 2010 
from smear positive new TB cases at four different health centres in Addis Ababa.  
Demographic, epidemiologic, and clinical information for all patients were collected using a 
prestructured questionnaire. All participants were tested for antibodies to HIV-1 and -2 after 
pre- and post-test counselling using a rapid test (Stat pack, KHP and Unigold as a tie braker) 
as per the Ethiopian National guide line. All sputum samples from TB cases were cultured for 
mycobacteria following the protocol described in the methodology section (2.4.6). M. 
tuberculosis isolates were identified using PCR-based genotyping with previously described 
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methods for RD9 deletions and genotyping was done using spoligotyping as described in the 
methodology part of the thesis (2.4.7 and 2.4.8). 
The spoligo patterns which were prepared in binary and octal were entered and  
determined by comparing the spoligotyping results with already existing designations in the 
international spoligotyping database, SpolDB4.0 (Brudey et al.; 2006) (http://www.pasteur-
guadeloupe.fr:8081/SITVITDemo). Families and subfamilies where assigned for patterns 
which were not registered by using the SpotClust program, which was built on the SpolDB3 
database (http://cgi2.cs.rpi.edu/_bennek/SPOTCLUST.html). 
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5.3 Result
5.3.1 Demographic information
Of the total 192 patients sampled, 26 (13.5%) were HIV positive, 136 (70.8%) were HIV 
negative and the remaining 30 (15.6%) were not tested for HIV. The mean age was 28.7 
years (range 18—72). There were slightly more male participants than female (56.9%). For 
the HIV-positive patients, the mean CD4 cell count at the time of presentation was 312
±22.4 cells/•L. 
5.3.2 Genetic diversity and family assignment
Among the 192 typed isolates, 169 (88%) were classified into one of the 33 STs according to 
SpolDB4.0. The remaining 23 isolates generated 20 different spoligotypes with 3 new shared 
spoligotypes (n=2 in each cluster) that had not been previously described in the database. 
Among the total 53 spoligotype patterns characterized in the present study, 20 patterns 
(including the 3 new clustered patterns) corresponding to clusters with 2-41 isolates per 
cluster were identified, accounting for a very high clustering rate of 88% (169/192). Out of 
the 33 patterns that did not form clusters, 17 represented true orphan patterns that did not 
previously exist in SpolDB4.0 and 16 represented pseudo-orphans which were present as 
singles in this study but found in SpolDB4.0 (The ST and Family distribution of clustered 
strains is summarized in Figure 5-1).
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Octal Code ST Family
No. of 
strains
in this 
study
% of 
strains 
in this 
study
ccccccccccccccccccccccccccccccccccggggggggg 000000000003771 1 BEIJING 1 0.5
gggccccggggggggggggggcccccccccccccggggggggg 703777700003771 142 CAS 2 1
gggccccgggggggggggggggccccccccccccccccccccc 703777740000000 1264 CAS 1 0.5
gggccccgggggggggggggggccccccccccccggccggggg 703777740003171 25 CAS_DELHI 18 9.4
gggccccgggggggggggggggccccccccccccggggggggg 703777740003771 26 CAS_DELHI 5 2.6
gggccccgcgggggggggggggccccccccccccggccggggg 702777740003171 140 CAS_DELHI 1 0.5
gggccccgggggggggggggggccccccccccccgggccgggg 703777740003471 247 CAS_DELHI 1 0.5
ggccccggcgggggggggccccccccccccccccggggggggg 606777000003771 21 CAS_KILI 14 7.3
gggggggggggggggggggggggggccccccgccccggggggg 777777774020771 47 H1 1 0.5
ccccccccccccccccccccccccggggggcgccccggggggg 000000007720771 3 H3 1 0.5
ggggggggggggggggggggggggggggggcgccccggggggg 777777777720771 50 H3 7 3.6
gggggggggggggggggggggggggcggggcgccccggggggg 777777775720771 121 H3 4 2.1
ggggggggggggggggggggggggggggggcgccccggccggg 777777777720631 134 H3 2 1
ggcgggggggggggggggggggggggggggcgccccgcggggg 677777777720571 699 H3 1 0.5
gggggggccgggggggggggggggggggcccgccccggggggg 774777777420771 262 H4 1 0.5
ggggggggggggggggggggggggggggcccgccccggggggg 777777777420771 777 H4 6 3.1
ggggggggggggggggggggggggggggcccgccccgggcggg 777777777420731 817 H4 1 0.5
gggggggggggggggggggcccccgccgggggccccggggggg 777777404760771 41 LAM7_TUR 1 0.5
ggggggggggggggggggggccccggggggggccccggggggg 777777607760771 42 LAM9 2 1
ggggggggggggggggggggggggggggggggccccggggggg 777777777760771 53 T1 21 10.9
gggggggggggggggggggggggcggggggggccccggggggg 777777767760771 373 T1 1 0.5
ggggggggggggggggggggggggggggggggccccggggcgg 777777777760751 612 T1 4 2.1
gggggggggggggggggggccccccgggggggccccggggggg 777777403760771 1688 T1 1 0.5
ggggggggggggggggggggggggggggggggccccgggcggg 777777777760731 52 T2 3 1.6
ggggggggggggggggcgggggggggggggggccccgggcggg 777775777760731 584 T2 4 2.1
ggggggggggggggggggcgggggggggggggccccgggcggg 777777377760731 1077 T2 1 0.5
ggggggggggggcgggggggggggggggggggccccgggcggg 777737777760731 73 T2-T3 1 0.5
ggggggggggggcgggggggggggggggggggccccggggggg 777737777760771 37 T3 14 7.3
gggggggggccccccccccgggggggggggggccccggggggg 777000377760771 149 T3_ETH 41 21.4
gggggggggccccccccccgggggggggggggccccgggcggg 777000377760731 345 T3_ETH 3 1.6
ggggggggggggggggggggggcgggggggggccccggggggg 777777757760771 44 T5 1 0.5
gggcccccccccccccccccccccgggccgggggggggggggg 700000007177771 910 U 3 1.6
ggggggggggggggggggggccccgggggcccccccccccggg 777777607600031 1689 U 1 0.5
gggggggggccccccccccggcggggggggggccccggggggg 777000337760771 Orphan Orphan 1 0.5
ggggggggggggggggggccccccgccgggggccccggggggg 777777004760771 Orphan Orphan 1 0.5
gccggggggcgggcggggcgcgggggggccccgcggggggggg 477357277413771 Orphan Orphan 1 0.5
gggccccggggcggggggggggccccccccccccggccggggg 703677740003171 Orphan Orphan 2 1
gggccccggcgggggggggcccccccccccccccggggggggg 703377400003771 Orphan Orphan 2 1
gggccccggcgggccgggggggccccccccccccggggcgggg 703347740003671 Orphan Orphan 1 0.5
gcgccggcgccccccccccgccggggcggggccccccgcggcg 515000236740261 Orphan Orphan 1 0.5
ggggggggggggggggggggccccggggggggccccgggcccg 777777607760701 Orphan Orphan 1 0.5
ggggcgggggggggggggcgggggggggggggccccggggggg 757777377760771 Orphan Orphan 1 0.5
gggggggggcggggggggggggggggggggggccccggggcgg 777377777760751 Orphan Orphan 1 0.5
gggcccccccccccccccccccccgccccggccgggggggccc 700000004147740 Orphan Orphan 2 1
ggggggggggggcccggggggggcgggccccgccccggggggg 777707767020771 Orphan Orphan 1 0.5
ggcgggggggggggggggggggggggcggccgccccgcggggg 677777776620571 Orphan Orphan 1 0.5
gggccccggggggggggggggggcccccccccccggggggggg 703777760003771 Orphan Orphan 1 0.5
ccccccggcgggcgggggggggggggggggggccccggggggg 006737777760771 Orphan Orphan 1 0.5
ggggggggggggggcccccgggggccccccccccccccccccc 777760370000000 Orphan Orphan 1 0.5
gggggccgggggggggggggggggggggcccgccccggggggg 763777777420771 Orphan Orphan 1 0.5
gggccccggcggggggggggcccccccccccccccgggggggg 703377600001771 Orphan Orphan 1 0.5
gggc1ccgggggcgggggggggcccccccccccccgccggggg 703737740001171 Orphan Orphan 1 0.5
gggggggggggggcgggggggggcggggggcgccccggggggg 777757767720771 Orphan Orphan 1 0.5
Webdings Format
Figure 5-1 Spoligotype pattern of clustered M. tuberculosis strains.
The black and white boxes indicate the presence and absence, respectively, of the specific 
spacer at position 1 to 43 in the DR locus. ST= Shared Type; CAS = Central Asian; LAM = Latin
American-Mediterranean; H=Haarlem, U= Unknown
Family assignment revealed that the T family represented the most predominant family in 
our study, constituted of 104, (54.2%) isolates with the following distribution: T3_ETH (44, 
22.9%); T1 (34, 17.7%), T2 (8, 4.2%); T2-T3 (1, 0.5%), T3 (16, 8.3%) and T5 (1, 0.5%). The CAS 
Families (50, 26%) were the second most dominant family with CAS1_DELHI (25, 13%); 
CAS_KILLI (14, 7.3%) and CAS (9, 4.7%). Other families found were Haarlem (H) (24, 12.5%) 
Stellenbosch University  http://scholar.sun.ac.za
122
with the following distribution: H1 (1, 0.5%), H3 (15, 7.8%), H4 (8, 4.2%);  the LAM Family (5, 
2.6%): LAM9 (4, 2.1%), LAM7_TUR (1, 0.5%); the Beijing Family (1, 0.5%); Family 34 (1, 
0.5%); Family 36 (1, 0.5%) and 4 (2.1%) strains were Undetermined (the main results of the 
spoligotyping analysis are summarized in Table 5-1). 
Table 5-1  Family and family distribution and associated ST for each isolate in the study
Family Family Shared Type, Number of 
isolates
Beijing n=1 (0.5%) Beijing  n=1 1,  n=1
CAS  n=50 (26%) CAS n=11 142,  n=2
1264,  n=1
Orphan, n=8
CAS1_KILI  n=14 21,  n=14
CAS_DELHI  n=25 25,  n=18
26,  n=5
140,  n=1
247,  n=1
H  n=24 (13.2%) H1  n=1 47,  n=1
H3  n=15 3,   n=1
50,  n=7
121,  n=4
134,  n=2
699,  n=1
H4  n=8 262,  n=6
777,  n=1
817,  n=1
LAM  n=5 (2.6%) LAM7_TUR  n=1 41,  n=1
LAM9  n=4 42,  n=2
Orphan, n=2
T  n=104 (54.2%) T1  n=34 53,  n=21
373,   n=1
612,   n=4
1688,  n=1
Orphan, n=7
T2  n=8 52,  n=3
584,   n=4
1077,  n=1
T2-T3  n=1 73,   n=1
T3  n=16 37,  n=14
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Orphan, n=2
T3_ETH  n=44
149,  n=41
345,  n=3
T5  n=1 44,   n=1
EAI n=1 (.5%) EAI5 Orphan, n=1
Family 34 n=1 (0.5%) Orphan, n=1
Family 36 n=2 (1%) Orphan, n=2
U n=4 (2.1%) U  n=4 910,   n=3
1689,  n=1
Among the total 33 Shared types which comprised 169 isolates, a total of 126 isolates 
(65.6%) from 8 clusters which contained 5-41 isolates per cluster formed the major isolates 
and 43 isolates (22.4%) from 25 clusters which contained 1-4 isolates per cluster formed the 
minor isolates. Sixteen isolates were pseudo orphans whereas 23 isolates generated 20 
unique spoligotypes that had not been previously described in the database. The 
spoligotype pattern of the orphan isolates is summarized in figure 5-2.
Octal Code ST Family* Probability**
No. of 
strains
in this 
study
% of 
strains 
in this 
study
gggggggggccccccccccggcggggggggggccccggggggg 777000337760771 Orphan T3 0.99 1 0.5
ggggggggggggggggggccccccgccgggggccccggggggg 777777004760771 Orphan LAM9 0.98 1 0.5
gccggggggcgggcggggcgcgggggggccccgcggggggggg 477357277413771 Orphan EAI5 0.99 1 0.5
gggccccggggcggggggggggccccccccccccggccggggg 703677740003171 Orphan CAS 0.99 2 1
gggccccggcgggggggggcccccccccccccccggggggggg 703377400003771 Orphan CAS 0.99 2 1
gggccccggcgggccgggggggccccccccccccggggcgggg 703347740003671 Orphan CAS 0.99 1 0.5
gcgccggcgccccccccccgccggggcggggccccccgcggcg 515000236740261 Orphan T3 0.99 1 0.5
ggggggggggggggggggggccccggggggggccccgggcccg 777777607760701 Orphan LAM9 0.99 1 0.5
ggggcgggggggggggggcgggggggggggggccccggggggg 757777377760771 Orphan T1 0.99 1 0.5
gggggggggcggggggggggggggggggggggccccggggcgg 777377777760751 Orphan T1 0.99 1 0.5
gggcccccccccccccccccccccgccccggccgggggggccc 700000004147740 Orphan FAMILY 36 0.99 2 1
ggggggggggggcccggggggggcgggccccgccccggggggg 777707767020771 Orphan T1/H3 0.22/0.77 1 0.5
ggcgggggggggggggggggggggggcggccgccccgcggggg 677777776620571 Orphan T1/H3 0.22/0.77 1 0.5
gggccccggggggggggggggggcccccccccccggggggggg 703777760003771 Orphan CAS 0.95 1 0.5
ccccccggcgggcgggggggggggggggggggccccggggggg 006737777760771 Orphan T1 0.99 1 0.5
ggggggggggggggcccccgggggccccccccccccccccccc 777760370000000 Orphan FAMILY 34 0.99 1 0.5
gggggccgggggggggggggggggggggcccgccccggggggg 763777777420771 Orphan T1/H3 0.22/0.99 1 0.5
gggccccggcggggggggggcccccccccccccccgggggggg 703377600001771 Orphan CAS 0.99 1 0.5
gggccccgggggcgggggggggcccccccccccccgccggggg 703737740001171 Orphan CAS 0.99 1 0.5
gggggggggggggcgggggggggcggggggcgccccggggggg 777757767720771 Orphan T1/H3 0.22/0.77 1 0.5
Webdings Format
Figure 5-2 Spoligotype pattern of orphan M. tuberculosis strains from HIV positive and HIV 
negative patients.
The black and white boxes indicate the presence and absence, respectively, of the specific 
spacer at position 1 to 43 in the DR locus * SpotClust program-assigned family. **Probability 
that the spoligotype pattern belongs to the family
5.3.3 Spoligopattern of isolates from HIV positive TB cases
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For the HIV positive patients, spoligotyping produced a total of 11 different patterns. Among 
the 26 patients, 25 (92.3%) were classified into one of the 10 shared international types 
(SITs) according to SpolDB4.0. The remaining 1 isolate generated a unique spoligotype 
pattern that had not been previously described in the database. Among the total 11 
spoligotype patterns characterized in the present study, 5 patterns corresponding to 
clusters with 2-5 isolates per cluster were identified and the remaining 5 patterns were 
pseudo orphans. One spoligotype represented a true orphan pattern that did not previously 
exist in SpolDB4.0. Family assignment in HIV positive subjects also revealed that the ill 
defined T family constitutes the most predominant family (38.5%) followed by H Family 
constituting 26.9% and CAS_DELHI (23.1%). Although the small sample size of HIV positive 
subjects did not allow us to make a strong comparison with HIV negative subjects, we did
not find a significant difference in the distribution of the different families in the two 
groups. The spoligo pattern of the isolates from HIV positive subjects is summarized in 
figure 5-3.
Octal Code ST Family
No. of 
strains
in this 
study
% of 
strains 
in this 
study
703777740003171 25 CAS_DELHI 4 15.4
gggccccgggggggggggggggccccccccccccggggggggg 703777740003771 26 CAS_DELHI 2 7.7
ggggggggggggggggggggggggggggggcgccccggggggg 777777777720771 50 H3 3 11.5
ggggggggggggggggggggggggggggcccgccccggggggg 777777777420771 777 H4 3 11.5
ggggggggggggggggggggggggggggcccgccccgggcggg 777777777420731 817 H4 1 3.8
gggggggggggggggggggcccccgccgggggccccggggggg 777777404760771 41 LAM7_TUR1 3.8
ggggggggggggcgggggggggggggggggggccccgggcggg 777737777760731 73 T2-T3 1 3.8
ggggggggggggcgggggggggggggggggggccccggggggg 777737777760771 37 T3 4 15.4
gggggggggccccccccccgggggggggggggccccggggggg 777000377760771 149 T3_ETH 5 19.2
gggcccccccccccccccccccccgggccgggggggggggggg 700000007177771 910 U 1 3.8
ggggggggggggggggggggccccggggggggccccgggcccg 777777607760701 Orphan Orphan 1 3.8
Webdings Format
gggccccgggggggggggggggccccccccccccggccggggg
Figure 5-3 Spoligotype pattern of M. tuberculosis strains from HIV positive subjects.
The black and white boxes indicate the presence and absence, respectively, of the specific 
spacer at position 1 to 43 in the DR locus.
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5.4 Discussion
Analysis and timely updates of the M. tuberculosis strain distributions in a given country and 
comparisons to worldwide patterns provides insights into transmission mechanisms, 
emergence of drug resistance and particularly virulent strains, and potentially information 
relevant to the development of new diagnostics, drugs and vaccines.
This study has been undertaken in HIV positive and HIV negative patients in order to gain a 
better understanding into the population structure of M. tuberculosis in Addis Ababa. 
Spoligotyping was used as a primary typing tool because of its ease of use, straightforward 
coding and existence of an international database of global isolates for comparative 
analysis. 
There are variations in different areas with regard to the distribution of the dominant 
families (Brudey et al.; 2006). In our study, the majority of the isolates (83.2%) belonged to 
three major families: T family (54.2%), CAS (26%) and H (13.2%) and there was no difference 
in the distribution of families in HIV positive and HIV negative subjects (Figure 5-4). 
Figure 5-4 M. tuberculosis spoligotype families in HIV positive and HIV negative patients
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Although the T family was the most prevalent in this study, it is believed that the T family 
does not represent a particular family and that it encompasses families which are not 
grouped into one of the other families (Brudey et al.; 2006). Hence it is frequently referred 
to as the "ill-defined" family of M. tuberculosis that is found worldwide. 
The T3_ETH was the dominant family and previous reports also showed this spoligotype 
present in high proportion in Ethiopia (Agonafir et al.; 2010) and it is believed to be specific 
for Ethiopia and this ST has not been reported from any other country (Brudey et al.; 2006).  
The CAS family, which was the second most frequent spoligotype in this study, had been 
reported in previous studies in Ethiopia (Agonafir et al.; 2010) and also prevalent in Tanzania 
(Kibiki et al.; 2007) with CAS1_KILI predominant and in Kenya 35.6% of 73 isolates were of 
the CAS family (Githui et al.; 2004). The H family constituted 13.2% of all families in our 
study and it is wide-spread in different geographical regions of the world such as Asia, 
Europe, Middle East and Africa has been documented with some reports associated with 
outbreaks in Argentina (Ritacco et al.; 1997) and in Czech Republic (Kubin et al.; 1999). 
The other families were LAM and Beijing comprising 5 and 1 isolates respectively. Among 
the LAM family we had two strains, LAM7_TUR and LAM9. The LAM7_TUR is believed to be  
a strain restricted to Turkey (Zozio et al.; 2005) where as LAM9 has been reported from 
different parts of the world including Africa. SIT1 corresponds to the Beijing genotype is the 
first report from Ethiopia but it needs to be confirmed with other molecular methods as 
spoligotyping has limitations for genotypic classification. The Beijing family is a common 
strain in East Asia but recent reports indicated this strain is distributed all over the world 
and it is taken as an indicator of recent introduction into a particular area. In recent years 
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several countries reported an increase over time of the proportion of TB due to Beijing 
genotype strains including countries in the region (Githui et al.; 2004; Kibiki et al.; 2007). 
Generally, despite the presence of predominant shared types, the diversity of the M. 
tuberculosis found in the present study is very high; 192 isolates produced 53 different 
spoligotypes. The families observed in this study represented more than 85.5% of the total 
62 families currently registered in the fourth international spoligotyping database, SpoID4. 
Spoligotyping has less discriminatory power; therefore, for a better understanding and 
confirmation of the diversity, more discriminative techniques will be required. Moreover, 
the effect of this diversity on M. tuberculosis transmission and whether strain differences 
might elicit different immune responses is not clear and it needs further study. Different 
studies have indicated that M. tuberculosis strains differ in their immunogenicity and 
virulence (de Jong et al.; 2008; Nicol and Wilkinson; 2008; Portevin et al.; 2011). It is also 
advisable to do follow up studies in order to obtain a clear molecular-epidemiological 
overview of the Beijing and other strains. This study was done in a few health centers in the 
capital city of Addis Ababa, so our findings here may not be representative of the entire 
country; therefore, we recommend future wider studies with a better molecular method 
with a better discriminative power like SNP typing to elucidate strain diversity in detail 
within Ethiopia. 
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CHAPTER 6
6. Plasma levels of IL 4 differ in patients infected with different 
modern lineages of M. tuberculosis
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Abstract
Background: The genetic diversity of Mycobacterium tuberculosis may have important 
clinical consequences. Epidemiological evidence from tuberculosis outbreaks suggested that 
the virulence, site of disease and capacity for transmission is not the same in all genotypes 
of M. tuberculosis. We analysed the plasma cytokine levels of untreated, first-episode
pulmonary tuberculosis patients infected with different strains of M. tuberculosis to test the 
hypothesis that immune responses would be linked to the bacterial genotype.
Methods: Spoligotyping was carried out for genotyping and we used Luminex technology to 
measure 17 cytokines (EGF, fractalkine, GM-CSF, IFN-g, IL-1, IL-10, IL-12, IL-17, IL-4, IL-7, IL-9, 
IP-10, MCP-1, MCP-3, MIP-1b, TNF and VEGF) from plasma samples of tuberculosis patients.
Result: The level of IL-12 (p40), IL-4, IL-7 and MIP-1betta were higher in patients infected 
with lineage 3 than lineage 4, however, it was only IL-4 which showed statistically significant 
difference (p<0.05) between the two lineages. We further grouped the lineages into 
different M. tuberculosis families (CAS, H and T family) and we found that the plasma level 
of IL-4 was significantly higher in patients infected with the CAS family (p<0.05) in 
comparison with T and H families. However there was no any difference between T and H 
family.
Conclusion: There is a significant difference in the plasma levels of IL-4 between patients 
infected with different lineages and families of the modern lineage. Whereas it is unknown 
if such differential cytokine responses are responsible for different clinical outcomes in 
hosts infected with these strains, further investigation should address this issue to improve 
our understanding of mechanisms for pathogenicity.. 
6.1 Introduction
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Tuberculosis remains a significant public health problem infecting one third of the world’s 
population resulting 8.8 million cases and 1.45 million deaths annually (WHO; 2011). The 
factors that lead to the considerable variability in the outcome of M. tuberculosis infection 
are complex and incompletely understood. Host genetics and environmental factors like 
prior exposure to non-pathogenic mycobacteria, HIV infection, advanced age, malnutrition, 
alcohol abuse, diabetes and corticosteroids have been associated with tuberculosis disease 
(Bellamy; 2003). There are studies that indicate that the different clinical outcomes of M. 
tuberculosis infection could be associated with the genotype of M. tuberculosis. There is 
growing evidence that the genetic diversity of M. tuberculosis may have important clinical 
consequences (Nicol and Wilkinson; 2008; Coscolla et al.; 2010). 
Epidemiological evidence from tuberculosis outbreaks suggested that the virulence, site of 
disease and capability of transmission is not the same in all genotypes of M. tuberculosis
(Hirsh et al.; 2004; Gagneux et al.; 2006). A number of studies have described the ‘‘Beijing 
family’’ to be hyper virulent with a reduced immune response leading to higher bacillary 
load and enhanced dissemination with rapid progression to severe disease in humans and 
experimental animals (Lopez et al.; 2003; Manca et al.; 2004; Hanekom et al.; 2007; Tanveer 
et al.; 2009).
A study in Gambia showed that progression to clinical disease was significantly less in 
individuals exposed to the ancient lineage compared to the modern lineage (de Jong et al.; 
2008) and another study in Madagascar reported significantly lower interferon-g production 
by peripheral blood T cells in individuals infected with the modern lineage 
(Rakotosamimanana et al.; 2010). Moreover, a recent study by Portevin et al also showed 
that measurement of cytokines from culture supernatants harvested 24 hours after 
Stellenbosch University  http://scholar.sun.ac.za
134
infection of human peripheral blood monocyte derived macrophages revealed clear 
differences in the level of proinflammatory cytokines produced by a single donor in 
response to different strains (Portevin et al.; 2011). 
In the present study, we used plasma samples from new pulmonary tuberculosis patients to 
test the hypothesis that immune response would be linked to the infecting genotype by 
measuring the plasma levels of different cytokines and chemokines.
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6.2 Materials and Methods
Patient recruitment
A total of 75 subjects with microbiologically confirmed new smear positive pulmonary TB 
patients attending Arada, T/Haimanot, Kirkos and W-23 health centres, Addis Ababa, who 
were infected with one of the three major families, T, H and CAS (previous chapter) were 
randomly selected from the total of 192 patients. 
Multiplex cytokine analysis, mycobacterium culture and DNA extraction, deletion typing, 
spoligotyping and spoligo database comparison was done as indicated in the methodology 
section of the thesis (2.4.3, 2.4.6-2.4.9).
Statistical analysis
The data were analyzed using Graph Pad Prism software, version 4.0. Nonparametric Mann–
Whitney U tests were performed to find the significance of the observed differences in each 
parameter in TB and other groups. A P value less than 0.05 was considered statistically 
significant.
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6.3 Result
6.3.1 Genetic diversity and family assignment
A total of 75 TB patients infected with M. tuberculosis belonging to lineages 3 and lineage 4 
were selected randomly from 192 patients. The lineage 3 comprises 22 CAS strains and 
lineage 4 comprises 35 T and 18 H strains. Of all the total 75 patients, 26 (34.6%) were 
females. The mean age was 28.7 years (range 18—64) and 31.7 years (range 18-59) for 
females. The representative spoligopattern is indicated in figure 6-1. 
Octal Code Family Lineage
gggccccggggggggggggggcccccccccccccggggggggg 703777700003771 CAS 3
gggccccgggggggggggggggccccccccccccccccccccc 703777740000000 CAS 3
gggccccgggggggggggggggccccccccccccggccggggg 703777740003171 CAS 3
gggccccgggggggggggggggccccccccccccggggggggg 703777740003771 CAS 3
ggccccggcgggggggggccccccccccccccccggggggggg 606777000003771 CAS 3
gggggggggggggggggggggggggccccccgccccggggggg 777777774020771 H 4
ccccccccccccccccccccccccggggggcgccccggggggg 000000007720771 H 4
ggggggggggggggggggggggggggggggcgccccggggggg 777777777720771 H 4
ggggggggggggggggggggggggggggcccgccccggggggg 777777777420771 H 4
ggggggggggggggggggggggggggggcccgccccgggcggg 777777777420731 H 4
ggggggggggggggggggggggggggggggggccccggggggg 777777777760771 T 4
ggggggggggggggggcgggggggggggggggccccgggcggg 777775777760731 T 4
ggggggggggggggggggcgggggggggggggccccgggcggg 777777377760731 T 4
ggggggggggggcgggggggggggggggggggccccggggggg 777737777760771 T 4
gggggggggccccccccccgggggggggggggccccggggggg 777000377760771 T 4
gggggggggccccccccccgggggggggggggccccgggcggg 777000377760731 T 4
Webdings Format
Figure 6-1 Representative spoligotype pattern of M. tuberculosis strains.
The black and white boxes indicate the presence and absence, respectively, of the specific 
spacer at position 1 to 43 in the DR locus. CAS = Central Asian; T = ill defined family; 
H=Haarlem.
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6.3.2 Plasma cytokine and chemokine levels of patients infected with 
different M. tuberculosis lineages
Plasma samples from 75 TB patients infected with strains belonging to lineage 3 (CAS) 
(n=22) and lineage 4 (H and T) (n=53) were analysed and we compared the plasma cytokine 
and chemokine levels between the two lineages. The level of IL-12 (p40), IL-4, EGF, IP-10 
and MIP-1b were higher in patients infected with lineage 3, however, it was only IL-4 which 
was significantly different between the two lineages (P=0.01250.05) (figure 6-2).
C
A B
*
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Figure 6-2 Plasma cytokine and chemokine levels in TB cases infected with different 
lineages.
Plasma samples from TB cases infected with lineage 3 (n=22), and lineage 4 (n=43) were
assessed by multiplex cytokine analysis. A) Anti-inflammatory cytokines (IL-10 and IL-4), B) 
Growth factors (EGF and VEGF), C) Pro-inflammatory cytokines (IFN-g, IL 12(p40), and TNF) 
and D) Chemokines (IP-10, MCP-1, MCP-3, MIP-1b and fractalkine). Horizontal lines indicate 
median levels of TB cases infected with lineage 3 (filled circles), and lineage 4 (open circles). 
Data were analysed using the nonparametric Mann-Whitney test with p-values indicating 
significant differences after transformation of data to Log2 values.*P<0.05.
D
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6.3.3 Plasma cytokine and chemokine levels of patients infected with 
different M. tuberculosis families
We further grouped the lineages into different M. tuberculosis families: 22 CAS, 35 T and 18 
H family and we found that only the level of IL 4 was significantly higher in plasma samples 
infected with the CAS family in comparison with H (P=0.024) and T (P<0.001)family. 
However, there was no difference between T and H family (Figure 6-3).
A B
C
*
**
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Figure 6-3 Plasma cytokine and chemokine levels in TB cases infected with different 
strains.
Plasma samples from TB cases infected with CAS (n=22), H (n=18) and T families (n=35) were
assessed by multiplex cytokine analysis. A) Anti-inflammatory cytokines (IL-10 and IL-4), B) 
Growth factors (EGF and VEGF), C) Pro-inflammatory cytokines (IFN-g, IL 12(p40), and TNF) 
and D) Chemokines (IP-10, MCP-1, MCP-3, MIP-1b and fractalkine). Horizontal lines indicate 
median levels of TB cases infected with the CAS family (filled circles), H family (open circles)
and T families (filled diamonds). Data were analysed using the nonparametric Mann-
Whitney test with p-values indicating significant differences after transformation of data to 
Log2 values.*P<0.05, ** P<0.001.
We also analysed the ratio of the main Th1 (IFN-g and IL-12(p40)) and Th2 (IL-4 and IL-10) 
hallmark cytokines, however, none of the ratios of IFN-g/IL-4, IFN-g/IL-10, IL-12(p40)/IL-4 
and IL-12(p40)/IL-10 were significantly different between patients infected with the 
different lineages or families (Figure 6-4).
D
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Figure 6-4 Th1/Th2 ratios of cytokines of TB cases infected with different strains.
Box plots are shown with the horizontal line indicating median levels of TB cases and the 
lower and upper edge of each box indicate the 25th and 75th percentiles, respectively. A) 
Ratio of Th1/Th2 cytokines (IFN-g/IL-4, IFN-g/IL-10, IL-12/IL-4 and IL-12/IL-10) of TB patients 
infected  with lineage 3 (white bars), and lineage 4 (grey bars); B) Ratio of Th1/Th2 cytokines 
(IFN-g/IL-4, IFN-g/IL-10, IL-12/IL-4 and IL-12/IL-10) of TB patients infected with CAS family 
(white bars), H family (grey bars) and T families (crossed bars). Data were analysed using the
nonparametric Mann-Whitney test with p-values indicating significant differences after 
transformation of data to Log2 values.
A
B
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6.4 Discussion
Understanding the effect of the genotype of an infecting organism in the pathogenesis of 
tuberculosis is becoming an essential question in tuberculosis research. It is well known that 
T cell responses play a fundamental role during M. tuberculosis infection where a strong T 
cell response leads to granuloma formation and maintenance whereas a defective T cell 
response favours progression of disease. In the present study, we analysed the plasma level 
of different cytokines and chemokines in TB cases who are diseased with different M. 
tuberculosis genotypes, which are common in Addis Ababa, Ethiopia. 
Strains belonging to the modern lineage were the only M. tuberculosis isolates circulating in 
the study community and we compared the plasma levels of cytokines and chemokines of 
patients infected with the different lineages and families within the modern lineage.  
Previous studies using laboratory and clinical strains have shown differences in immune 
response against different M. tuberculosis isolates.  For example, strain NH878 has been 
associated with a low inflammatory immune response and increased virulence in
macrophages and animal models compared to H37Rv, H37Ra, Erdman and CDC1551 (Manca 
et al.; 1999; Manca et al.; 2001; Manca et al.; 2005; Tsenova et al.; 2005). A recent study 
also showed a wide variation in the immune response after measurement of cytokines from 
infected human peripheral blood monocyte derived macrophages where modern lineages 
induced lower inflammatory responses in comparison with ancient lineages. This lower 
immune response might promote more rapid disease progression and increase transmission 
in the case of modern lineages (Portevin et al.; 2011). 
In our study we compared the plasma level of 17 cytokines, which belong to 
proinflammatory cytokines, anti-inflammatory cytokines, angiogenic factors and 
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chemokines, in tuberculosis patients infected with different M. tuberculosis strains of the 
modern lineage. The plasma level of IL-9, IL-17, IL-7, TNF and GM-CSF was present in very 
low concentrations in all patients regrdless of strains. Although detectable, no significant 
difference in levels of EGF, fractalkine, IFN-g, IL-1, IL-10, IL-12(p40), IL-7, IP-10, MCP-1, MCP-
3, MIP-1b, and VEGF was found between patients infected with different lineages and 
families. We found that only the plasma level of IL-4 was significantly higher in patients 
infected with lineage 3 (p<0.05) as compared to lineage 4. We further grouped the lineages 
into families and similarly, it was IL-4 which showed statistical difference between the 
different families where patients infected with CAS family had a higher plasma level of IL-4 
(P<0.05) as compared to patients infected with H and T family but there was no difference 
between H and T families. 
Previous studies reported lower inflammatory responses associated with modern strains 
including Beijing and other strains (Lopez et al.; 2003; Chacon-Salinas et al.; 2005; Portevin 
et al.; 2011) where low inflammatory responses were linked to increased virulence (Manca 
et al.; 2004; Newton et al.; 2006). Another study in Madagascar also showed lower IFN-g
responses in tuberculosis patients and their contacts that are infected with ancient strains, 
like East African-Indian (EAI) strains than modern M. tuberculosis strains, like Beijing and 
Central Asian (CAS) strains. 
Although we did not compare the two broad lineages of M. tuberculosis, ancient and 
modern lineage, we clearly saw a marked difference in the plasma level of IL-4 within
families of the modern lineage. IL-4 is an anti inflammatory cytokine and there are 
hypotheses that higher level of IFN-g and lower level of IL-4 are required for the 
maintenance of an effective Th1 response against M. tuberculosis. IL-4 suppresses 
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macrophage derived production of IL-12, thereby inhibiting differentiation of Th1 cells and 
inhibits cell mediated immune reactions by antagonizing the macrophage activating effect 
of IFN-g. Therefore, the higher level of IL-4 in lineage 3 families might indicate that strains 
belonging to this family could be more virulent than the lineage 4 families of modern 
lineages. This present study is too small and was not designed to allow the detection of 
clinical differences between infections with different strains, including extent of disease, 
presence of cavitation and treatment response but should be investigated in future studies. 
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CHAPTER 7
7. General Discussion
Stellenbosch University  http://scholar.sun.ac.za
149
The immune response against M. tuberculosis is multifaceted, involving a network of innate 
and adaptive immune responses. Characterizing the immune response of tuberculosis, a 
clear understanding of the dynamics and identification of biomarkers which can discriminate
between active tuberculosis disease and latent tuberculosis infection, identifying persons 
most likely to advance to active disease and relapse after treatment are critically needed in
order to make a significant impact on and curb the global tuberculosis problem.  
In the last decade or so, a lot of research has been conducted to identify biomarker(s) which 
may be translated into clinical and public health programs as simple and inexpensive point-
of-care tests to distinguish between the different outcomes of infection and anti 
tuberculosis treatment (Wallis et al.; 2009; Kaufmann; 2010; Parida and Kaufmann; 2010; 
Wallis et al.; 2010; Walzl et al.; 2011). As part of the global effort of studying tuberculosis 
biomarkers, we investigated: 1) transcription of host genes in tuberculosis cases and their 
contacts and effect of HIV on the gene expression of co-infected cases; 2) plasma cytokine 
and chemokine levels of tuberculosis patients and their contacts; 3) strain diversity in the 
study area; and 4) the immunological consequence of tuberculosis cases infected with the 
different M. tuberculosis genotypes under the EDCTP and BMGF funded tuberculosis 
consortium projects.  
Biomarker studies based on transcriptomics are one of the current research interests of 
different laboratories to identify genes which can discriminate tuberculosis cases and 
latently infected individuals, predict durable cure and indicating reactivation risk. In our 
study, we analysed 45 genes and the expression of IL-4d2, BLR-1, MARCO, CCL-19, IL7R, Bcl2, 
FcgR1A, MMP9 and LTF genes discriminate tuberculosis cases and their healthy contacts. 
The genes, which showed significant discriminatory expression between contacts and 
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tuberculosis cases in this study include molecules of the innate and adaptive immune 
response. Previous studies had also shown that LTF, FcgR1A, RAG33A (Jacobsen et al.; 2007), 
CD3e, CD8a, IL7R, BLR1, CD19, FcgR1A, CXCL10, CD4, TNF, Bcl2, MMP9, FoxP3, CASP8, CCL-4, 
TNRFSF1A, CASP8 and TNF (Joosten et al.; 2012) genes were differentially expressed and can 
discriminate between tuberculosis patients, latent infection, and uninfected people. 
Expression levels of RIN3, LY6G6D, C14orf2, SOCS3, KIAA2013, TEX264, ASNA1, ATP5G1, and 
NOLA3 identify subjects at risk for recurrent tuberculosis (Mistry et al.; 2007). 
From the previously published as well as the current data there are genes that showed a 
similar pattern of expression in different settings and population. Although there are 
drawbacks in the transcriptomic platforms due to regional differences in host and microbial
genetics and the lack of specificity for tuberculosis of the differentially expressed genes, the 
transcriptional data described above might be converted into clinically useful tools after 
verifying across different populations and in larger sample sizes. Across the different 
transcriptomic studies genes related to macrophages, B cells and T cells were identified. This 
expanded scope of immune paths beyond T cells is important and in any future biomarker 
study, due emphasis needs to be given equally to cells and molecules of both adaptive and 
innate immune responses. 
On the other hand there are genes like FoxP3, TGFb1 and CCL-19 that were upregulated in 
latently infected individuals in comparison with uninfected individuals. The upregulation of 
these genes could be due to the fact that this group of subjects were individuals who had 
recent contact with tuberculosis cases and recent infection, which may lead to limited 
immune activation and at the same time immune regulation to prevent immunopathology. 
Up-regulation of CCL-19 facilitates the recruitment of different cells. Up-regulation of both 
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pro- and anti-inflammatory markers in latently infected individuals who do not develop 
active TB during the two-year follow-up period suggests that a delicate balance between 
different immune phenotypes is required. A recent study reported that IL-2 induces 
activation and expansion of both T effector cells and Foxp3 (+) Treg populations early in M. 
tuberculosis infection and confers resistance against severe M. tuberculosis disease (Chen et 
al.; 2012). 
Disease protection, progression or development of pathophysiology in tuberculosis have
been linked to the type and magnitude of cytokines and chemokines that are produced, 
however, the specific cytokines that mediate immunologic resistance or susceptibility to 
mycobacteria in humans remain undefined. Cytokines and chemokines like IFN-g (Goldsack 
and Kirman; 2007), TNF (Keane; 2005), IL-12(p40) (Verreck et al.; 2002), IL-17 (Khader et al.; 
2007), CCL-2 (Kipnis et al.; 2003), CCL-3, CCL-4 and CCL-5 (Saukkonen et al.; 2002), CXCL-8 
(Kurashima et al.; 1997), CXCL-9 and CXL-10 (Sauty et al.; 1999) have been reported to be 
important for control of M. tuberculosis infection. 
Several studies have been conducted to identify cytokines and chemokines, which could be 
associated with protection or susceptibility. High level of Th1 cytokine gene expression in 
unstimulated PBMC (IFN-g and IL-12) and the IL-4 antagonist IL-4d2 were found in protected 
individuals in comparison with non protected individuals (Demissie et al.; 2004). 
Proinflammatory cytokines such as TNF, IL-12(p40) and IL-17 in 7 day stimulation of whole 
blood with TB antigens (ESAT-6/CFP-10 (EC), PPD or TB10.4) are increased in tuberculosis cases 
and can discriminate between active tuberculosis disease and latent infection (Sutherland et 
al.; 2010), Tuberculosis cases also have high levels of IL-8, IP10, MCP-1, and MIP-1 b in 
serum/plasma in comparison with non tuberculosis cases (Juffermans et al.; 1999; Azzurri et 
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al.; 2005; Siawaya et al.; 2009). One study adapted the commercial QFT assay, where 
detection of a combination of three host markers or single markers (selected from EGF, 
sCD40L, MIP-1•, VEGF, TGF-• or IL-1•) in stimulated or unstimulated plasma samples had
promising discriminating ability between latent and active tuberculosis (Chegou et al.; 
2009). In our study we measured unstimulated plasma cytokines with a panel of 17 
cytokines and we found a significant discriminatory ability of plasma cytokine and 
chemokine levels between tuberculosis cases versus their contacts and in tuberculosis cases 
before and after treatment.
The type of plasma cytokines which showed a significant discriminatory power between 
tuberculosis cases and the contacts were Th1 (IFN-g), Th2 type (IL-4), chemokines (IP-10, 
fractalkine and MCP-3) and a growth factor (EGF). The plasma cytokine pattern in 
tuberculosis cases showed a higher level of chemokines, an anti-inflammatory response and 
a suppressed proinflammatory response when compared with that of household contacts. 
The individual cytokines differentiated the clinical groups by themselves but it was their 
combination, which gave a better discriminatory power. 
Although plasma cytokines are not specific to tuberculosis, from this and other previous 
studies directly ex vivo unstimulated plasma samples should be for considered for future 
study as the sample represents the systemic activation within the host but also reflects the 
local immune response (host markers will be released into the circulations after local 
production); moreover, plasma is easy to collect and does not need additional laboratory 
procedures. In addition, we measured the plasma level of cytokines in relation to TB 
treatment and we showed a significant difference in the level of several cytokines before 
and after treatment. Previous studies also showed a significant difference of plasma 
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cytokines and chemokines (Azzurri et al.; 2005; Siawaya et al.; 2009a), which strengthens
the argument for the measurement of these cytokines as potential surrogate markers for 
anti tuberculosis treatment response.
Apart from the host genetics and environmental influences (Bellamy; 2005), the genotype of 
the pathogen also affects the type of immune response and the outcome of M. tuberculosis
infection (Coscolla et al.; 2010). The different genotypes of M. tuberculosis are associated 
with specific geographical human populations and currently there are six major lineages of 
M.tuberculosis based on large sequence polymorphisms. Studies showed that  
M. tuberculosis originated in Africa and was distributed to the other parts of the world 
accompanying movement of the modern human (Gagneux; 2012).
We characterized 192 M. tuberculosis isolates from new smear positive tuberculosis 
patients in Addis Ababa using spoligotyping and all the isolates were members of the 
modern lineage (Lineages 3 and 4). In comparison with the phylogenetically ancient lineage, 
the modern M. tuberculosis lineages are more successful in terms of their geographical 
spread (Gagneux; 2012) and this could be the reason why all the isolates in Addis Ababa 
were members of the modern lineage,  contrary to the historical African origin of M. 
tuberculosis. Members of the modern lineage are believed to be more virulent with a 
shorter latency in humans and this characteristic could explain the global success of the 
these lineages (Portevin et al.; 2011). In our study almost half of the isolates belonged to 
one family, the T family, which belongs to the Lineage 4 or Euro-American lineage. The T 
family encompasses by default strains that could not be classified in one of the families with 
well-established phylogeographical specificity (Brudey et al.; 2006). Hence it is frequently 
referred to as the "ill-defined" family of M. tuberculosis that is found worldwide. 
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We assessed the plasma cytokine levels of tuberculosis cases infected with the different 
genotypes of M. tuberculosis to test the hypothesis that immune response would be linked 
to the infecting genotype. There was a marked difference in the plasma levels of IL-4 
between lineages of phylogenetically modern strains. IL-4 is an anti inflammatory cytokine 
and there are hypothesizes that suggest that higher levels of IFN-g and lower level of IL-4 are 
required for the maintenance of an effective Th1 response against M. tuberculosis. The 
maintenance of a prolonged Th1 response against M. tuberculosis requires not only
elevation of IFN-g, but also downregulation of IL-4. There are several other studies which 
showed immune response differences amongst M. tuberculosis isolates where the modern 
lineages induced a significantly lower immune response in comparison with the ancient 
lineages (Portevin et al.; 2011). The present study is in keeping with this as IL-4 suppresses 
Th1 responses.
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CHAPTER 8
8. Conclusion
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Tuberculosis continues to be a major global health problem, causing an estimated 8.8 
million new cases and 1.45 million deaths annually despite the availability of a vaccine and 
inexpensive, effective, and reasonably well-tolerated therapy. It is true that the current 
available tools to diagnose, treat and protect are ineffective to combat tuberculosis. 
Therefore, novel intervention measures comprising rapid and reliable diagnostics, new 
vaccines for uninfected or latently infected people and new drugs for patients with active 
tuberculosis disease need to be developed to make substantial progress towards the goal of 
tuberculosis elimination. 
Developing simple, affordable and rapid methods for detecting active cases, discriminating 
and diagnosing active tuberculosis disease and latent tuberculosis infection, identifying 
persons most likely to progress to active disease and relapse after treatment are more 
critical than ever before and will have a significant impact on the global tuberculosis 
problem. This is particularly true for developing countries where the incidence of active and 
latent tuberculosis is high and where smear microscopy is the only technique widely used 
for active case detection. A reliable test for latent infection would be valuable to guide 
interventions in those most likely to progress to active TB, including HIV infected people and 
young children.  
Currently studies are on-going in many laboratories using serum, plasma, stimulated whole 
blood, PBMC, saliva and other samples to identify molecules which can be used as a 
biomarker for indicating or predicting the different clinical outcome of M. tuberculosis
infection. In our study, as part of  the Grand Challenges in Global Health (GCGH) consortium 
supported by BMGF, as well as the Africa-European Tuberculosis Consortium (AE TBC) 
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supported by EDCTP and with a focus on tuberculosis biomarkers, we used multiplex 
technologies i.e., Multiplex Ligation Dependent Probe Amplification (MLPA) technique for 
transcriptomics and Luminex for multiplex analysis of cytokines and chemokines. We also 
characterized M. tuberculosis isolates and analysed the effect of genotype on immune 
response by measuring plasma cytokine and chemokine levels using Luminex.
In the transciptomics study we analysed forty-five genes from whole blood sample and we 
found a number of genes which alone, or in combination, gave a promising discriminatory 
power to differentiate between tuberculosis cases and their contacts and latently infected 
versus uninfected individuals. Similarly, the multiplex analysis of cytokines and chemokines 
also showed that single or combination of plasma cytokines and chemokines discriminate 
the different clinical groups of tuberculosis. Major drawbacks of our studies include the use 
of peripheral blood samples for biomarker discovery in view of the known 
compartmentalization of immune responses as well as the lack of specificity of non-
stimulated samples for TB as many other inflammatory conditions may induce similar 
responses. However, peripheral blood remains an attractive sample type due to the ease 
with which this sample can be obtained and unstimulated samples remain attractive as ex 
vivo, rapid tests have many advantages over stimulated tests that only yield results after 
lengthy culture periods and that require significant laboratory expertise and infrastructure. 
In both the transcriptomics and multiplex study, we identified genes or cytokines, which had 
been reported from other studies with different designs and in different settings, thereby 
validating such results. The observed differences in the plasma level of cytokines and 
chemokines in tuberculosis patients infected with different strains of M. tuberculosis,
however, emphasize the needs to take geographical factors into consideration in any future 
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similar work and also raise the issue that a greater focus should be given to markers that are 
not so dependent on infection strains.
It is clear that no single transcript or cytokine or chemokine stand out as promising 
biomarkers on their own but that combinations of such markers hold the greatest promise. 
The exact composition of such biosignatures seems to allow some flexibility and depends on 
the specific clinical situation, on bacterial strains that are prevalent and may also be affected 
by host genetic and environmental factors. 
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